10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED:  September 30, 2013

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: ________________

ORIGINOIL, INC.

 (Exact name of registrant as specified in its charter)

Nevada	26-0287664
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

5645 West Adams Blvd

Los Angeles, CA 90016

 (Address of principal executive offices, Zip Code)

(323) 939-6645

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x       No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x       No  o      

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  o	Accelerated filer o
Non-accelerated filer o	Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  o     No x

The number of shares of registrant’s common stock outstanding, as of November 18, 2013 was 48,653,092.

1

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	23
Item 4.	Controls and Procedures.	23
Item 1.	Legal Proceedings.
Item 1A.	Risk Factors.	24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	24
Item 3.	Defaults Upon Senior Securities.	24
Item 4.	Mine Safety Disclosures.	24
Item 5.	Other Information.	24
Item 6.	Exhibits.	24
SIGNATURES		25

2

PART I - FINANCIAL INFORMATION ORIGINOIL, INC.

ORIGINOIL, INC.

CONDENSED BALANCE SHEETS

	September 30, 2013			December 31, 2012
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	1,298,576		$	507,355
Accounts receivable		20,000			25,000
Work in process		64,600			35,666
Prepaid expenses		121,167			186,978
Other receivables		-			1,200
TOTAL CURRENT ASSETS		1,504,343			756,199
PROPERTY & EQUIPMENT
Machinery & equipment		76,794			32,670
Furniture & fixtures		27,056			27,056
Computer equipment		29,789			28,824
Leasehold improvements		94,914			94,914
		228,553			183,464
Less accumulated depreciation		(151,330	)		(140,067	)
NET PROPERTY & EQUIPMENT		77,223			43,397
OTHER ASSETS
Investment		20,000			20,000
Patents		449,166			317,689
Trademark		4,467			4,467
Security deposit		9,650			9,650
TOTAL OTHER ASSETS		483,283			351,806
TOTAL ASSETS	$	2,064,849		$	1,151,402
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	42,395		$	353,200
Accrued expenses		175,564			376,846
Derivative liability		2,677,675			355,526
Convertible promissory notes, net of discount of $727,562 and 237,965, respectively		1,166,793			435,365
Unsecured notes payable, net of discount of $0 and $38,639, respectively		-			171,361
Total Current Liabilities		4,062,427			1,692,298
Long Term Liabilities
Convertible note payable, net of discount of $139,087		151,473			-
Total Long Term Liabilities		151,473			-
TOTAL LIABILITIES		4,213,900			1,692,298
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value;
25,000,000 authorized preferred shares		-			-
Common stock, $0.0001 par value;
250,000,000 authorized common shares
43,552,023 and 17,967,545 shares issued and outstanding		4,355			1,797
Additional paid in capital		33,352,943			27,024,419
Accumulated deficit		(35,506,349	)		(27,567,112	)
TOTAL SHAREHOLDERS' DEFICIT		(2,149,051	)		(540,896	)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	2,064,849		$	1,151,402

The accompanying notes are an integral part of these condensed financial statements

3

ORIGINOIL, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30, 2013			September 30, 2012			September 30, 2013			September 30, 2012
Sales	$	40,500		$	30,726		$	140,500		$	583,889
Cost of Goods Sold		19,866			13,543			50,510			420,906
Gross Profit		20,634			17,183			89,990			162,983
Operating Expenses
Selling and general and administrative expenses		1,689,260			1,310,532			3,349,921			4,024,066
Research and development		318,244			152,978			755,595			590,416
Total Operating Expenses		2,007,504			1,463,510			4,105,516			4,614,482
Loss before Depreciation and Amortization		(1,986,870	)		(1,446,327	)		(4,015,526	)		(4,451,499	)
Depreciation & amortization expense		4,508			3,401			11,263			10,203
Loss from Operations before Other Income/(Expenses)		(1,991,378	)		(1,449,728	)		(4,026,789	)		(4,461,702	)
OTHER INCOME/(EXPENSE)
Gain (Loss) on settlement of debt and extinguishment of derivative liability		2,446,467			-			2,310,953			(838,728	)
Gain (Loss) on change in fair value of derivative liability		(1,343,167	)		30,696			(3,543,781	)		(14,716	)
Fair value of discounted warrants		(645,398	)		-			(645,398	)		-
Commitment fee		(213,229	)		-			(997,893	)		-
Foreign exchange loss		-			(611	)		-			(2,838	)
Interest expense		(248,152	)		(502,752	)		(1,036,329	)		(1,664,069	)
TOTAL OTHER INCOME/(EXPENSE)		(3,479	)		(472,667	)		(3,912,448	)		(2,520,351	)
NET LOSS	$	(1,994,857	)	$	(1,922,395	)	$	(7,939,237	)	$	(6,982,053	)
BASIC DILUTED LOSS PER SHARE	$	(0.05	)	$	(0.16	)	$	(0.27	)	$	(0.69	)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED		41,620,654			12,211,940			29,367,986			10,136,415

The accompanying notes are an integral part of these condensed financial statements

4

ORIGINOIL, INC.

CONDENSED STATEMENT OF SHAREHOLDERS' DEFICIT

(Unaudited)

									Additional
	Preferred stock				Common stock				Paid-in			Accumulated
	Shares		Amount		Shares		Amount		Capital			Deficit			Total
Balance at December 31, 2012		-	$	-		17,967,545	$	1,797	$	27,024,419		$	(27,567,112	)	$	(540,896	)
Common stock issued at prices of $0.125 and $0.25 per share for cash		-		-		12,270,172		1,227		2,266,315			-			2,267,542
Common stock issued for services at fair value ranging in prices between $0.31 and $0.63		-		-		1,991,198		199		793,552			-			793,751
Common stock issued for conversion of debt
(prices per share of $0.11 and $0.875)		-		-		10,511,236		1,051		1,850,735			-			1,851,786
Common stock issued upon exercise of warrants at fair value through a cashless exercise		-		-		332,960		33		(33	)		-			-
Common stock issued for warrants at $0.25 per share for cash		-		-		478,912		48		119,681			-			119,729
Fair value of discounted warrants		-		-		-		-		704,575			-			704,575
Beneficial conversion feature on note		-		-		-		-		161,422			-			161,422
Stock and warrant compensation cost		-		-		-		-		432,277			-			432,277
Net loss for the nine months ended September 30, 2013		-		-		-		-		-			(7,939,237	)		(7,939,237	)
Balance at September 30, 2013		-		-		43,552,023	$	4,355	$	33,352,943		$	(35,506,349	)	$	(2,149,051	)

The accompanying notes are an integral part of these condensed financial statements

5

ORIGINOIL, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	September 30, 2013			September 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(7,939,237	)	$	(6,982,053	)
Adjustment to reconcile net loss to net cash
used in operating activities
Depreciation & amortization		11,263			10,203
Common stock and warrants issued for services		793,751			934,943
Stock compensation expense		223,277			878,604
Loss on change in valuation of derivative liability		3,254,328			24,607
Debt discount and beneficial conversion feature recognized as interest expense		922,152			1,461,223
Gain on settlement of debt		(2,310,953	)		838,728
Common stock issued for incentive fees		-			21,000
Original issue discount amortized as interest		-			92,662
Non cash interest and commitment fee expense		1,320,810			-
Fair value of discounted warrants		704,575			-
Changes in Assets and Liabilities
(Increase) Decrease in:
Accounts receivable		5,000			(80,726	)
Prepaid expenses		65,811			536,981
Work in progress		(28,934	)		219,658
Other receivables		1,200			15,427
Increase (Decrease) in:
Accounts payable		(20,245	)		(86,524	)
Accrued expenses		7,718			15,289
Deferred income		-			(278,163	)
NET CASH USED IN OPERATING ACTIVITIES		(2,989,484	)		(2,378,141	)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(45,089	)		(12,500	)
Patent expenditures		(131,477	)		(97,089	)
NET CASH USED IN INVESTING ACTIVITIES		(176,566	)		(109,589	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from unsecured subordinated debt		-			1,579,578
Payments for unsecured debt		(10,000	)
Proceeds from convertible promissory notes		1,580,000			-
Proceeds for issuance of common stock		2,387,271			808,896
NET CASH PROVIDED BY FINANCING ACTIVITIES		3,957,271			2,388,474
NET INCREASE/(DECREASE) IN CASH		791,221			(99,256	)
CASH BEGINNING OF PERIOD		507,355			197,868
CASH END OF PERIOD	$	1,298,576		$	98,612
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	-		$	5,262
Taxes paid	$	-		$	-
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Conversion of accounts payable into a long term convertible note	$	290,560		$	-
Extinguishment of fair value of derivative liability	$	1,378,774		$	-
Beneficial conversion	$	161,422		$	-
Fair Value of options issued to officer in prior year	$	209,000		$	-
Common stock issued for conversion of notes	$	1,851,786		$	851,089

The accompanying notes are an integral part of these condensed financial statements

6

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

 1.   Basis of Presentation

The accompanying unaudited condensed financial statements of OriginOil, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included.  Operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.  For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2012.

Going Concern

The accompanying condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying condensed financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the nine months ended September 30, 2013, the Company did not generate significant revenue, incurred a net loss of $7,939,237 and cash used in operations of $2,989,484.  As of September 30, 2013, the Company had a working capital deficiency of $2,709,557 and a shareholders’ deficit of $2,149,051.   These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern.  Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2012 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders in the nine months ended September 30, 2013, and has standing purchase orders and open invoices with customers. Management believes this funding will continue from its’ current investors and has also obtained funding from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as it is received, and the equipment has been fully accepted by the customer. Returns are based upon each rent-to-own agreement, and revenue would be adjusted based on a pro-rata basis on the unused months of quarterly payments. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have either a purchase agreement or rental agreement signed by the customer with a payment arrangement.  This is a critical policy, because we want our accounting to show only sales which have a final payment arrangement.

We also recognize revenue for services associated with the equipment setup, provided it is part of the rent-to-own agreement.

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of six months or less to be cash equivalents.

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for employee options or warrants were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2013, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

7

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

The fair value of the Company's common stock option grant is estimated using the Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2013:

	Total		(Level 1)		(Level 2)		(Level 3)
Other Asset
Investment	$	20,000	$	-	$	-	$	20,000
Total assets measured at fair value	$	20,000	$	-	$	-	$	20,000
Liabilities
Derivative Liability	$	2,677,675	$	-	$	-	$	2,677,675
Convertible Debenture, net of discount		1,318,266		-		-		1,318,266
Total liabilities measured at fair value	$	3,995,941	$	-	$	-	$	3,995,941

8

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Use of Estimates

The preparation of the condensed financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

 Reclassification

Certain expenses for the nine months ended September 30, 2012 were reclassified to agree with the classification for the current period.

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies which instruments and transactions are subject to the offsetting disclosure requirements established by ASU 2011-11. This guidance is effective for annual and interim reporting periods beginning January 1, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other accounting pronouncements did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

9

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

3.  CAPITAL STOCK

During the nine months ended September 30, 2013, the Company issued 1,991,198 shares of common stock for services with prices ranging from $0.25 up to $0.63 with a total fair value of $793,751.  The shares issued were valued at the trading price at the date of the agreement.

During the nine months ended September 30, 2013, the Company issued 494,020 shares of common stock of which 247,010 shares were associated with the settlement of a convertible promissory note for principal in the amount of $200,000 and interest in the amount of $16,134, and additional shares of 247,010 as an inducement to convert issued with the notes with a fair value of $123,946 based upon the trading price of our common stock at the date of the agreement.

During the nine months ended September 30, 2013, the Company issued 10,017,216 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $1,527,840 based upon a conversion price of $0.11 up to $0.875.

During the nine months ended September 30, 2013, the Company issued 332,960 shares of common stock in exchange for a cashless exercise of 454,911 purchase warrants.

During the nine months ended September 30, 2013, the Company issued 478,912 shares of common stock upon exercise of the purchase warrants in the amount of 478,912 for cash in the amount of $119,729.

During the nine months ended September 30, 2013, the Company received proceeds for issuance of common stock for cash of $2,267,542 for the purchase of 12,270,172 shares of common stock at prices per share ranging from $0.12 to $0.25.  Included in the purchase are one-year warrants to purchase an aggregate of 13,192,750 shares of common stock, three-year warrants to purchase an aggregate of 11,762,547 shares of common stock and five-year warrants to purchase an aggregate of 17,230,775 shares of common stock. Each warrant is exercisable at a price per share between $0.15 up to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like.

4. OPTIONS AND WARRANTS

Options

The Board of Directors adopted the OriginOil, Inc., 2009 Incentive Stock Option Plan (the “2009 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Five Hundred Thousand (500,000) shares of Common Stock.  

On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc., 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for One Million (1,000,000) shares of Common Stock.  Options granted under these Plans may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc., 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Four Million (4,000,000) shares of Common Stock.  Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the Optionee or their representative shall have the right to exercise the portion of any Options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

10

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

4.  STOCKS AND WARRANTS (Continued)

With respect to Non-statutory Options granted to employees, directors or consultants, the Board or Committee may specify such period for exercise that the Option shall automatically terminate following the termination of employment or services as to shares covered by the Option as the Board or Committee deems reasonable and appropriate.

During the nine months ended September 30, 2013, the Company granted 533,498 incentive stock options to employees with an estimated fair value of approximately $122,705 using the Black-Scholes-Merton calculation. The options are exercisable at $0.41/share, vest monthly after 90 days from grant date over a period of five (5) years and expire in ten (10) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $1,076 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company granted 2,532,665 Non-statutory stock options under the 2013 Stock Option Plan to employees and board of directors with an estimated fair value of approximately $582,513 using the Black-Scholes-Merton calculation. The options are exercisable at $0.38/share up to $0.44/share, vest over a period of five (5) and expire in ten (10) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $34,472 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company granted 500,000 options under the 2013 Stock Option Plan to an employee with an estimated fair value of approximately $70,000 using the Black-Scholes-Merton calculation. The options are exercisable at $0.29/share, vest immediately and expire in five (5) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $70,000 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company recorded $117,729 of compensation cost based on the vesting of the options granted to employees, directors and consultants in prior periods. Future unamortized compensation expense on the unvested outstanding options at September 30, 2013 is approximately $961,818.

In fiscal 2012, the Board of Directors agreed to grant an officer of the Company options to purchase 759,645 shares of common stock at $0.43 per share.  Upon grant, the options vested immediately and will expire in 5 years.  Total fair value of the options granted amounted $209,000 determined using the Black-Scholes Option Pricing Model and was recorded in 2012 and reflected in compensation cost and as due to officer which is included as part of Accrued Expenses in the accompanying Balance Sheet.  In April 2013, the Board formally approved the issuance of the 759,645 options and the amount was reclassified from due to officer to Additional Paid in Capital.

A summary of the Company’s stock option activity and related information follows:

	September 30, 2013
				Weighted
	Number			average
	of			exercise
	Options			price
Outstanding, beginning of period		465,294		$	1.67
Granted		4,325,808			0.41
Exercised		-			-
Forfeited/Expired		(6,459	)		-
Outstanding, end of period		4,784,643		$	0.52
Exercisable at the end of period		1,563,696		$	0.57
Weighted average fair value of
options granted during the period				$	0.41

11

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

4.  STOCKS AND WARRANTS (Continued)

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of  September 30, 2013 was as follows:

						Weighted		Weighted		Weighted
						Average		Average		Average
		Stock		Stock		Remaining		Exercise Price		Exercise Price
Exercisable		Options		Options		Contractual		of Options		of Options
Prices		Outstanding		Exercisable		Life (years)		Outstanding		Exercisable
$	7.20		1,667		1,261		1.98	$	0.46	$	0.46
$	4.50		33,334		15,451		2.15	$	0.53	$	0.53
$	6.00		16,500		10,431		2.23	$	0.36	$	0.36
$	4.20		13,334		6,530		2.79	$	0.36	$	0.36
$	5.15		10,000		4,685		2.88
$	1.70		4,000		1,750		3.01	$	0.36	$	0.36
$	0.89		60,000		18,719		8.76	$	0.36	$	0.36
$	0.89		200,000		58,230		8.84	$	0.36	$	0.36
$	0.89		120,000		32,439		8.93	$	0.36	$	0.36
$	0.43		759,645		759,645		9.54	$	0.36	$	0.36
$	0.43		500,000		500,000		9.76	$	0.36	$	0.36
$	0.41		533,498		4,677		9.96	$	0.36	$	0.36
$	0.44		599,999		35,508		9.96
$	0.38		1,932,666		114,370		9.96
			4,784,643		1,563,696

Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the nine months ended September 30, 2013, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of September 30, 2013 based on the grant date fair value estimated.

Warrants

During the nine months ended September 30, 2013, in conjunction with the Company’s issuance of shares of common stock for cash, the Company granted warrants to purchase a total of 37,427,384 shares of our common stock.  Each warrant is exercisable at a price per share between $0.15 up to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like and will expire in one up to five years from date of grant (see Note 3).

During the nine months ended September 30, 2013, a total of 933,824 purchase warrants were exercised for a total of 811,872 shares of common stock (see Note 3).

During the nine months ended September 30, 2013, the Company amended the exercise price of approximately 4,308,000 warrants issued in 2012, from $0.65 per share to $0.25 per share. The Company calculated the change in fair value of the warrants before and after the modification using the Black Scholes Pricing Option Model and recorded an expense in the statements of operations during the nine months ended September 30, 2013 amounted to $704,575.

A summary of the Company’s warrant activity and related information follows:

	September 30, 2013
				Weighted
				average
				exercise
	Options			price
Outstanding -beginning of period		7,098,104		$	0.79
Granted		37,883,896			0.20
Exercised		(933,824	)		0.30
Forfeited		(857,805	)		1.26
Outstanding - end of period		43,190,371		$	0.31

12

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

4.  STOCKS AND WARRANTS (Continued)

At September 30, 2013, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	9.30		223,338		223,338		0.75
$	10.20		28,335		28,335		0.88
$	9.00		9,168		9,168		1.06
$	8.70		3,334		3,334		1.12
$	8.40		667		667		1.33
$	8.70		5,000		5,000		1.66
$	5.70		7,334		7,334		1.84
$	4.50		3,334		3,334		1.95
$	4.20		8,334		8,334		1.98
$	4.20		33,334		33,334		1.99
$	3.60		8,334		8,334		2.08
$	4.50		33,334		33,334		2.15
$	4.20		13,335		13,335		2.16
$	6.00		133,334		133,334		2.23
$	6.00		33,334		33,334		2.24
$	6.30		8,334		8,334		2.47
$	5.70		4,001		4,001		2.50
$	6.90		33,334		33,334		2.71
$	6.90		33,334		33,334		2.96
$	1.90		80,000		80,000		3.01
$	6.90		33,334		33,334		3.21
$	1.47		260,000		260,000		3.57
$	0.65		80,000		80,000		3.86
$	0.65		20,000		20,000		4.05
$	0.65		50,000		50,000		4.08
$	0.25		124,000		124,000		4.50
$	0.25		250,000		47,500		4.79
$	0.25		57,692		8,654		4.97
$	0.89		100,000		100,000		9.13
$	0.15 - 0.65		41,512,493		41,512,493		0.01 - 4.70
			43,190,371		42,938,833

5.  UNSECURED PROMISSORY NOTES

In January 2012, the Company issued its “January 2012 Notes” for gross proceeds of $1,669,828.  The notes matured in one year upon issuance, accrued interest at 8% per annum and were payable on the conversion date and/or at maturity. The January 2012 Notes were also redeemable by the Company, at the holder’s option, at maturity at a redemption price of 112% of the outstanding principal plus accrued and unpaid interest. At December 31, 2012, the January 2012 Notes had an aggregate remaining principal amount of $210,000.

13

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

5. UNSECURED PROMISSORY NOTES (Continued)

During the period ended September 30, 2013, the Company issued 494,020 shares of common stock in conversion of a principal amount of $200,000, with 247,010 upfront shares for a fair value of $123,946. The remaining $10,000 was paid in cash to the holder.  As a result of the settlement, the Company recognized a loss of $123,946 to account for the fair value of the shares of common stock issued which was recorded as part of the gain and loss on settlement of debt in the accompanying Statement of Operations.

The aggregate principal amount outstanding at September 30, 2013 was $0.

6. CONVERTIBLE PROMISSORY NOTES

June 2012 Convertible Promissory Notes

On June 20, 2012, the Company received an initial advance of $100,000 in consideration for the issuance of a note in the principal amount of $400,000 on a securities purchase agreements entered into for the sale of a 10% convertible promissory note, with an aggregate sum of $400,000, plus warrants to purchase an aggregate of up to 615,384 shares of the Company’s common stock at a purchase price of $0.65 per share. At closing, which took place simultaneously with execution of the securities purchase agreement, the Company issued the note with an outstanding principal sum of $100,000 together with a warrant to purchase 153,846 shares of the Company’s common stock. Under the terms of the securities purchase agreement, the investor had the option to advance an additional $300,000 in principal under the note and receive further warrants to purchase an aggregate of up to 461,538 shares of the Company’s common stock. The note originally matured six months from the date of each purchase made under the note, and bore interest at a rate of 10% per annum, which increased to 15% when the note was not repaid by September 18, 2012. The Note was originally convertible into shares of the Company’s common stock at a conversion price of $0.65. The warrants may be exercised at any time for a period of four years from the date of issuance at an exercise price of $0.65.

On February 15, 2013, the Company and the lender entered into an amendment to the note providing for, among other things, an extension of the maturity date of the note until July 21, 2013 and the amendment of the conversion price of the note to the lesser of $0.65 or 70% of the average of the three lowest closing prices in the 25 trading days previous to a conversion., During the month of June, 2013, the lender advanced another $100,000 under the securities purchase agreement, bringing the total outstanding principal due under the note to $300,000. Simultaneous therewith, the Company issued to the lender a warrant to purchase 153,846 shares of the Company's common stock. During the nine months ended September 30, 2013, the lender converted $124,208 of the convertible notes, plus accrued interest of $15,000, leaving a remaining principal balance of $175,792. During the nine months ended September 30, 2013, the Company recognized interest expense of $30,000.

        March 2013 Convertible Promissory Notes

As of March 31, 2013, the Company had issued convertible promissory notes to various investors in an aggregate principal amount of $665,000 with an original issue discount of $221,665.  The convertible notes were originally convertible into the common stock of the Company at conversion prices ranging from $0.4375 to $0.65.  As a result of most favored nations protection accorded to the convertible notes, the conversion price of the convertible notes is the lesser of $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price of common stock on any trading day after issuance of the convertible notes. The maturity dates of the notes are ninety (90) days from their effective date, with a one-time aggregate interest charge of $31,332, which will be amortized over ninety (90) days and recorded as interest expense.  If the convertible notes are not repaid on maturity, then the maturity date shall be automatically extended for up to three further 30 day periods and an extension fee of 25% of the then outstanding principal, interest and other fees shall be added to the principal amount of the notes at the end of each 30 day period that the convertible notes are still outstanding.  The convertible notes issued in February and March, 2013, to various investors in an aggregate principal amount of $235,000, with an aggregate original issue discount of $78,333, provide that for as long as the convertible notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the convertible notes or such other convertible notes or a term was not similarly provided to the purchaser of the convertible notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the convertible notes and such other convertible notes.

During the nine months ended September 30, 2013, the lenders converted principal of $405,000 plus original issue discount of 201,667, accrued interest and extension fees for an aggregate amount of $764,991. As of September 30, 2013, the remaining principal balance plus the original issue discount, accrued interest and fees was $601,562.

May 2013 Convertible Promissory Notes

On May 1, 2013, the Company issued convertible notes in an aggregate principal amount of $125,000.The notes mature six (6) months from the date of issuance and bear interest at 10% per annum. The notes may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the notes.  The Company has the right to enforce a conversion floor price of $0.40 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013 the remaining principal balance was $125,000. During the nine months ended September 30, 2013, the Company recognized interest expense of $5,205.

On May 21, 2013, the Company entered into a convertible promissory note for the payment of an accounts payable in the amount of $290,560. The note bears no interest and matures on December 31, 2015. The Company may pay the note in full on or before the maturity date without penalty. The note may be converted into common shares of the Company’s common stock at a conversion price of 75% of the average lowest three (3) last sale prices during the 25 trading days immediately preceding the date of delivery. As the conversion price of the note was less than the market price of the Company common stock at the date of its issuance, the Company determined that the note contained a beneficial conversion feature of 161,422. The note’s beneficial conversion feature is  considered as debt discount and is being amortized over the life of the Note. Amortization of debt discount for the nine months ended September 30, 2013 was $22,335.

On May 28, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures six (6) months from the date of issuance and bears interest at 10% per annum. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.45 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.40 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance was $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $8,663.

14

July 2013 Convertible Promissory Note

On July 16, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured, and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.35 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $5,310.

August 2013 Convertible Promissory Notes

On August 28, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.35 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.30 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $2,305.

September 2013 Convertible Promissory Notes

On September 27, 2013, the Company issued a convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.35 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the note or such other convertible note or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the note and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $210.

The agreements governing the Convertible Notes discussed above, excluding the convertible note date May 21, 2013 of $290,560, includes an anti-dilution provision that allows for the automatic reset of the conversion price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the current conversion price of the Amended Notes or exercise price of the warrants issued with the Convertible Notes. The Company considered the current FASB guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that the conversion price of the Convertible Notes are not a fixed amount because they are subject to fluctuation based on the occurrence of future offerings or events. As a result, the Company determined that the conversion features are not considered indexed to the Company’s own stock and characterized the initial fair value of these warrants as derivative liabilities upon issuance. The Company determined the aggregate initial fair value of the embedded beneficial conversion feature of the Conversion Notes issued during the period ended September 30, 2013 to be $2,033,406. These amounts were determined by management with the use of weighted average Black-Scholes Merton option pricing model. As such, the Company recorded a$1,371,705 valuation discount upon issuance of the notes. The Company is amortizing this valuation discount to interest expense over the life of the notes. During the nine month ended September 30, 2013 the Company included in interest relating to the amortization of this discount, and as of September 30, 2013 and December 31, 2012, the unamortized balance of the note discount was $727,562 and $276,604, respectively.

15

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

7.    DERIVATIVE LIABILITIES

In June 2008, the FASB issued authoritative guidance on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. Under the authoritative guidance, effective January 1, 2009, instruments which did not have fixed settlement provisions were deemed to be derivative instruments. As a result, certain convertible notes issued related to the private placement described in Notes 6 do not have fixed settlement provisions because their conversion prices may be lowered if the Company issues securities at lower prices in the future. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.  At December, 31, 2012, the outstanding fair value of the convertible notes accounted as derivative liabilities amounted to $355,526.

During the period ended September 30, 2013, as a result of convertible notes (“Note”) we issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $2,033,406, based upon a Black-Sholes-Merton calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. As the aggregate fair value of these liabilities of $2,033,406 exceeded the aggregate Note value of $1,580,000, the excess of the liability over the Note value of $453,406 was considered as a cost of the private placement and reported in the accompanying Statement of Operation as part of the change in derivative liability.

During the period ended September 30, 2013, approximately $779,208 convertible notes were converted.  As a result of the conversion of these notes, the Company recorded a gain of $2,310,953 due to the extinguishment of the corresponding derivative liability.  Furthermore, during the period ended September 30, 2013, the Company recognized a loss of $3,543,781 to account for the change in fair value of the derivative liabilities.  At September 30, 2013, the fair value of the derivative liability was $2,677,675.

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

Risk free interest rate		.05% - .72	%
Stock volatility factor		29.13% - 86.88	%
Weighted average expected option life	6 months - 4 years
Expected dividend yield	None

8.   SUBSEQUENT EVENTS

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following:

Between October 1, 2013 and October 28, 2013, a Lender under a prior securities purchase agreement, converted an aggregate principal and interest amount of $90,792 into an aggregate of 551,507 shares of the Company’s common stock.

Between October 1, 2013 and October 29, 2013, holders of original issuance discount convertible promissory notes issued between December 2012 and March 2013 in the aggregate principal, fees and interest amount of $315,105, converted the notes in full into an aggregate of 2,931,214 shares of the Company’s common stock.

Between October 7, 2013 and October 23, 2013, holders of warrants to purchase up to an aggregate of 154,924 shares of the Company’s common stock at an exercise price of $0.25 per share delivered notices of election to partially exercise the warrants on a cash basis resulting in the issuance of 153,924 shares of the Company’s common stock for an aggregate purchase price of $38,481.

16

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2013

On October 30, 2013, the Company issued a Convertible Note (“Note”) with an aggregate principal amount of $255,000. The Note matures nine (9) months from the date of issuance and bears interest at 10% per annum. The Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.30 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Note.  The Note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default under the Note, the Company shall be required to repay a mandatory default amount in cash equal to 150% of the outstanding principal amount of the Note plus accrued and unpaid interest and other fees due thereon and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Note or such other convertible notes or a term was not similarly provided to the purchaser of the Note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Note and such other convertible notes.

On November 1, 2013, holders of convertible promissory notes issued in May 2013 in the aggregate principal and interest amount of $131,301, converted the notes in full into an aggregate of 1,221,408 shares of the Company’s common stock.

During the subsequent period, the Company issued 243,016 shares of common stock for services at fair value of $72,374.

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Form 10-Q contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control, which may include statements about our:

● business strategy;

● financial strategy;

● intellectual property;

● production;

● future operating results; and

● plans, objectives, expectations and intentions contained in this report that are not historical.

All statements, other than statements of historical fact included in this report, regarding our strategy, intellectual property, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this report. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved.  These statements may be found under “Management's Discussion and Analysis of Financial Condition and Results of Operations,” as well as in this report generally.  Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors.  In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur.

Organizational History

OriginOil, Inc. (“we”, “us”, “our”, the “Company” or “OriginOil”) was incorporated on June 1, 2007 under the laws of the State of Nevada.  We have only been engaged in our current and proposed business operations since June 2007, and to date, we have been primarily involved in research and development activities.  Our principal offices are located at 5645 West Adams Blvd., Los Angeles, California 90016. Our telephone number is (323) 939-6645. Our website address is www.originoil.com.   Our website and the information contained on our website are not incorporated into this quarterly report.

Overview of Business

OriginOil has developed a breakthrough water cleanup technology for the oil & gas, algae and other water-intensive industries.

Unlike other technologies, our patent-pending Electro Water Separation™ (EWS) process rapidly and efficiently removes organic material from large quantities of water without the need for chemicals.

EWS, our breakthrough water cleanup technology, is a high-speed, chemical-free process that efficiently extracts organic contaminants from very large quantities of water.  It is the core technology powering OriginOil’s innovative product line that spans multiple industries. These include:

Algae Harvesting

EWS is used cost-effectively to harvest algae, intact and bacteria-free, without chemicals, at a continuously high flow rate. Systems can be operated in parallel for increased throughput rates. Built-in intelligence ensures a minimum of operator intervention.

Oil and Gas Water Cleanup

When applied to the oil and gas industry, EWS technology is used in a continuous process to remove oils, suspended solids, insoluble organics and bacteria from produced and frac flowback water in well operations. This allows the water to be easily recycled for future fracking operations or disposed of safely.

Aquaculture Water Cleanup

EWS operates in a continuous, chemical-free loop to dramatically reduce ammonia levels, and kill up to 98% of bacteria and other invaders, potentially eliminating antibiotics usage. Optionally, it can produce nitrate-rich water to grow algae for highly nutritious and cost-effective fish feed.

18

Organic Waste Remediation (still in prototype phase)

In many applications, such as agriculture, fish farming and animal farming, EWS can efficiently remove organic contaminants and pathogens from incoming or outgoing water supplies.

Business Model for All Applications

At this early stage, to prove our systems for wide-scale distribution and licensing, we must build, sell and support our system to companies making use of such systems.

Our long-term business model is based on licensing this technology to distributors, manufacturers, engineering service firms, and specialty operators, as well as fuel refiners, chemical and oil companies. We are not in the business of producing and marketing oil or fuel as an end product, nor of engaging in volume manufacturing.

We have only been engaged in our current and proposed business operations since June 2007. While continuing to engage in research and development, we recently moved into the commercialization phase of our business plan.

Recent Developments

· On February 5, 2013, we announced that we partnered with an aquaculture producer to study the impact of their technology in transforming a $100 billion global market.

· On February 13, 2013, we announced that we strengthened our focus on frack water cleanup and launched a licensing group to accelerate commercialization in secondary markets.

· On February 28, 2013, we announced that our CLEAN-FRAC™ water treatment system yields successful first field results.

· On March 13, 2013, we announced that we teamed up with another California startup to challenge Halliburton’s costs for cleaning produced water and frack water.

· On April 2, 2013, we announced that we accelerated commercialization of our CLEAN-FRAC system with the first commercial unit planned for 3rd quarter.

· On April 26, 2013, we announced that we enhanced third party testing showing 99% oil and solids removal, further validating our CLEAN-FRAC process.

· On May 9, 2013, we announced that Garden State bioEnterprises adopted our technology for high-value astaxanthin harvesting.

· On May 15, 2013, we announced that we named a manufacturer for our new performance-based frack water cleanup program.

· On June 25, 2013, we announced that New Global Energy will implement our water sanitizing and algae production technology as part of its strategy to acquire and restart shuttered fish farms in the Coachella Valley region of Southern California.

· On July 2, 2013, we announced that AlgEternal Technologies LLC will incorporate our technology to harvest algae as a key component of their proprietary algal production system.

· On July 10, 2013, we announced that we will establish a permanent technology showcase at Aqua Farming Technology in California’s Coachella Valley.

· On July 11, 2013, we announced that we expanded our algae and aquaculture designs to achieve commercial scale.

· On July 18, 2013, we announced that our technology can successfully treat liquid sewage directly at the point of origin, in commercial buildings.

19

· On July 24, 2013, we announced that we have initiated two consulting agreements with top water treatment engineering firms to validate the efficacy of its technology in the oil and gas and aquaculture markets.

· On July 31, 2013, we announced that we received our second international patent for our algae harvesting technology. The patent was issued by the Japan Patent Office.

· On August 6, 2013, we announced that we launched our Throughput Program for EWS Petro.

· On August 14, 2013, we announced the launch of our mid-sized algae harvester, designed, with producer input, for distributed algae production.

· On August 21, 2013, we announced today that AmericaCNG has selected EWS for the treatment of frac flowback and produced water.

· On August 29, 2013, we announced that after successful implementation and testing at its Weimar, Texas site, algae technology company AlgEternal will integrate EWS into its commercial algae production platform for paying customers in the US and overseas as early as the fourth quarter.

· On September 25, 2013, we announced that Algae Enviro Engineering, a Singapore-based photobioreactor systems provider and algae food producer, has adopted EWS technology for its algae production plant in Jurong, Singapore.

· On September 30, 2013, we announced that licensee PearlH2O has scheduled the installation of a commercial-scale three-quarter barrel per minute Frac-Back™ system in California’s Monterey Formation during the fourth quarter of 2013.

· On October 8, 2013, we announced today that we have signed our first pay-per-barrel agreement with Industrial Systems, Inc., for a water treatment system integrating OriginOil’s process as the first stage of treatment.

· On October 22, 2013, we announced that we have agreed to transfer three of our early patent applications to our French joint venture, Ennesys.

· On October 29, 2013, we announced that we have tripled the capacity of our entry-level algae harvester from four to twelve liters per minute at no additional cost, with improved energy efficiency.

Critical Accounting Policies

The Securities and Exchange Commission ("SEC") defines "critical accounting policies" as those that require application of management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within the SEC definition. 

Revenue Recognition

We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.

Fair Value of Financial Instruments

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2013, the amounts reported for cash, prepaid expenses, accounts payable and accrued expenses approximate the fair value because of their short maturities.

Recently Issued Accounting Pronouncements

Management reviewed accounting pronouncements issued during the three months ended September 30, 2013, and the following pronouncements were adopted during the period.

In January 2013, the Financial Accounting Standards Board (“FASB”) issued ASU 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies which instruments and transactions are subject to the offsetting disclosure requirements established by ASU 2011-11. This guidance is effective for annual and interim reporting periods beginning January 1, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

20

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other accounting pronouncements did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Results of Operation

Results of Operations for the three months ended September 30, 2013 compared to the three months ended September 30, 2012.

Revenue and Cost of Sales

Revenue for the three months ended September 30, 2013 and 2012 was $40,500 and $30,726, respectively. Cost of sales for the three months ended September 30, 2013 and 2012, was $19,866 and $13,543, respectively. To date we have had minimal revenues due to our focus on product development and testing. In addition, our equipment sales are primarily for trial purposes, intended for licensing or private labeling type transactions, which we believe have the potential to yield stronger long term revenue.

Operating Expenses

Selling and General Administrative Expenses

Selling and general administrative (“SG&A”) expenses increased by $378,728 to $1,689,260 for the three months ended September 30, 2013, compared to $1,310,532 for the three months ended September 30, 2012. The majority of the increase in SG&A expenses was due primarily to an increase in outside services of $353,939, investor and public relations of $152,010, and other G&A expenses of $50,449. The increase was partly offset by an overall decrease in non-cash stock compensation expense of $177,670.

Research and Development Cost

Research and development (“R&D”) costs increased by $165,266 to $318,244 for the three months ended September 30, 2013, compared to $152,978 for the three months ended September 30, 2012. The increase in overall R&D costs was primarily due to an increase in building and testing new aquaculture and algae designs and outside services for aquaculture, algae appliances and fracking research.

Other Income and Expenses

Other income and (expenses) decreased by $469,188 to (3,479) for the three months ended September 30, 2013, compared to (472,667) for the three months ended September 30, 2012. The overall decrease was the result of a foreign exchange loss in the amount of $611, interest expense of 254,600, which includes amortization of debt discount and beneficial conversion feature recorded as interest expense. The decrease was partly offset by an increase in gain on extinguishment of derivative liability in the amount of $2,446,467, commitment fees in the amount of $213,229, and net loss on change in fair value of derivative instruments and warrant discount of $1,373,863 and $645,398 respectively. The overall increase in these accounts are the result of debt financing with the issuance of convertible promissory notes.

Net Loss

Our net loss increased by $72,462 to $1,994,857 for the three months ended September 30, 2013, compared to a net loss of $1,922,395 for the three months ended September 30, 2012. The majority of the increase in net loss was due primarily to the increase in operating expenses of $543,994, gross profit of $3,451, depreciation of $1,107, with a decrease in other income and expenses of $469,188. Currently, operating costs exceed revenue because sales are not yet sufficient to cover costs.  We cannot assure of when or if revenue will exceed operating costs.

21

Results of Operations for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012.

Revenue and Cost of Sales

Revenue for the nine months ended September 30, 2013 and 2012 was $140,500 and $583,889, respectively. Cost of sales for the nine months ended September 30, 2013 and 2012, was $50,510 and $420,906, respectively. To date we have had minimal revenues due to our focus on product development and testing.  In addition, our equipment sales are primarily for trial purposes, intended for licensing or private labeling type transactions, which we believe have the potential to yield stronger long term revenue.

Operating Expenses

Selling and General Administrative Expenses

Selling and general administrative (“SG&A”) expenses decreased by $674,146 to $3,349,921 for the nine months ended September 30, 2013, compared to $4,024,067 for the nine months ended September 30, 2012. The majority of the decrease in SG&A expenses was due primarily to the decrease in non-cash stock compensation expense of$655,327, professional fees of $480,443, marketing and investor relations of $87,869, insurance of $31,371, and other G&A expenses of $319. The decrease was partly offset by an increase in outside services of $446,916, payroll expenses of $98,143, shipping of $18,270, and rent of $17,855.

Research and Development Cost

Research and development (“R&D”) costs increased by $165,179 to $755,595 for the nine months ended September 30, 2013, compared to $590,416 for the nine months ended September 30, 2012.   The increase in overall R&D costs was primarily due to an increase in building and testing new aquaculture and algae designs and outside services for aquaculture, algae appliances and fracking research.

Other Income and Expenses

Other income and (expenses) increased by $1,392,097 to ($3,912,448) for the nine months ended September 30, 2013, compared to ($2,520,351) for the nine months ended September 30, 2012. The increase was the result of an increase in net loss on change in fair value of derivative instruments of $3,529,065, increase in fair value of warrant discount of $645,398, commitment fees in the amount of $997,893, and gain on extinguishment of derivative liability in the amount of $3,149,680, with an offset by decreases in interest expense of $627,739, which includes amortization of debt discount and beneficial conversion feature recorded as interest expense, loss on foreign exchange in the amount of $2,838.. The overall increase is the result of debt financing with the issuance of convertible promissory notes.

Net Loss

Our net loss increased by $957,183 to $7,939,237 for the nine months ended September 30, 2013, compared to a net loss of $6,982,054 for the nine months ended September 30, 2012. The majority of the increase in net loss was due primarily to the increase in other income and expenses in the amount of $1,392,097and depreciation of $1,060, with a decrease in gross profit of 72,993 operating expenses of $508,967. Currently operating costs exceed revenue because sales are not yet sufficient to cover costs.  We cannot assure of when or if revenue will exceed operating costs.

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

The condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the nine months ended September 30, 2013, the Company did not generate significant revenue, incurred a net loss of $7,939,237 and cash used in operations of $2,989,484. As of September 30, 2013, the Company had a working capital deficiency of $2,709,557 and a shareholders’ deficit of $2,149,051. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2012 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders in the nine months ended September 30, 2013, and has standing purchase orders and open invoices with customers. Management believes this funding will continue from its’ current investors and has also obtained funding from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations.

22

At September 30, 2013 and December 31, 2012, we had cash of $1,298,576 and $507,355, respectively and working capital deficit of $2,558,084 and $936,099 respectively.  The increase in working capital deficit was primarily due to the increase in derivative liability and debt financing.

During the first three quarters of 2013, we raised an aggregate of $1,580,000 in an offering of unsecured convertible notes and $2,387,271 in an offering of shares of our common stock and warrants.  During the subsequent period, we raised an aggregate of $255,000 for unsecured convertible notes and $38,481 upon the exercise of warrants to purchase shares of our common stock.  The opinion of our independent registered public accounting firm on our audited financial statements as of and for the year ended December 31, 2012 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.   Our ability to continue as a going concern is dependent upon raising capital from financing transactions and future revenue.

Net cash used in operating activities was $2,989,484 for the nine months ended September 30, 2013, compared to $2,378,141 for the prior period September 30, 2012. The increase of $611,343 in cash used in operating activities was primarily due to the net decrease in prepaid expenses, work in process, other receivables, with an increase in accounts payable, accrued expenses, and net loss. The net loss includes non-cash expenses of depreciation, stock issued for services, loss on change in valuation of derivative liability, debt discount and original issue discount, commitment fees and stock compensation expense.  Currently, operating costs exceed revenue because sales are not yet significant.

Net cash flows used in investing activities for the nine months ended September 30, 2013 and 2012 were $176,566 and $109,089 respectively.  The net increase in cash used in investing activities was due to an increase in patent expenditures and research equipment.

Net cash flows provided by financing activities was $3,957,271 for the nine months ended September 30, 2013, as compared to $2,388,474 for the prior period September 30, 2012.  The increase in cash provided by financing activities was due to an increase in debt and equity financing.  To date we have principally financed our operations through the sale of our common stock and the issuance of debt.

We do not have any material commitments for capital expenditures during the next twelve months.  Although our proceeds from the issuance of convertible debt, our offering of shares of common stock and warrants together with revenue from operations are currently sufficient to fund our operating expenses, we will need to raise additional funds in the future so that we can expand our operations. Therefore, our future operations are dependent on our ability to secure additional financing.  Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms.  However, the trading price of our common stock and a downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. The inability to obtain additional capital may restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, we may have to curtail our marketing and development plans and possibly cease our operations.

We have estimated our current average burn, and believe that we have assets to ensure that we can function without liquidation over the next nine months, due to our cash on hand, our ability to raise money from our investor base and future expected revenue.  Based on the aforesaid, we believe we have the ability to continue our operations for the foreseeable future and will be able to realize assets and discharge liabilities in the normal course of operations.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 4.  Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We have adopted and maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC’s rules and forms and that the information is gathered and communicated to our management, including our Chief Executive Officer (Principal Executive Officer and Principal Financial Officer), as appropriate, to allow for timely decisions regarding required disclosure.

23

As required by SEC Rule 15d-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 15d-14 as of the end of the period covered by this report. Based on the foregoing evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in timely alerting them to material information required to be included in our periodic SEC filings and to ensure that information required to be disclosed in our periodic SEC filings is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure about our internal control over financial reporting.

Changes in Internal Controls

There have been no changes in our internal control over financial reporting during the most recent fiscal quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

Item 1.  Legal Proceedings.

None.

Item 1A. Risk Factors.  

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

 None.

Item 3.  Defaults Upon Senior Securities.

None.

Item 4.  Mine Safety Disclosures

Not applicable.

Item 5.  Other Information.

None.

Item 6.  Exhibits.

Exhibit Number	Description of Exhibit
31	Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
32	Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code.
101.INS	XBRL Instance Document.*
101.SCH	XBRL Taxonomy Extension Schema.*
101.CAL	XBRL Taxonomy Extension Calculation Linkbase.*
101.DEF	XBRL Taxonomy Extension Definition Linkbase.*
101.LAB	XBRL Taxonomy Extension Label Linkbase.*
101.PRE	XBRL Extension Presentation Linkbase.*

* Attached as Exhibit 101 to this report are the following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statement of Operations, (iii) the Statement of Shareholders’ Equity, (iv) the Statement of Cash Flow, and (v) Notes to Financial Statements.

24

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORIGINOIL, INC.
By:	/s/ T Riggs Eckelberry
	T Riggs Eckelberry
	Chief Executive Officer (Principal Executive Officer)
	and Acting Chief Financial Officer (Principal Accounting and Financial Officer)
	November 19, 2013

25

EX-31.1

EXHIBIT 31

CERTIFICATION

I, T Riggs Eckelberry, certify that:

1. I have reviewed this quarterly report on Form 10-Q of OriginOil, Inc., for the quarter ended September 30, 2013;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

    (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others, particularly during the period in which this report is being prepared;

    (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

    (c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

    (d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

    a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

    b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 19, 2013

/s/ T Riggs Eckelberry

T Riggs Eckelberry

Chief Executive Officer (Principal Executive Officer)

and Acting Chief Financial Officer

(Principal Accounting and Financial Officer)




EX-32.1

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of OriginOil, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, T Riggs Eckelberry, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

November 19, 2013	/s/ T Riggs Eckelberry
	T Riggs Eckelberry
	Chief Executive Officer (Principal Executive Officer)
	and Acting Chief Financial Officer (Principal Accounting and Financial Officer)

XML

Summary Of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as it is received, and the equipment has been fully accepted by the customer. Returns are based upon each rent-to-own agreement, and revenue would be adjusted based on a pro-rata basis on the unused months of quarterly payments. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have either a purchase agreement or rental agreement signed by the customer with a payment arrangement.  This is a critical policy, because we want our accounting to show only sales which have a final payment arrangement.

We also recognize revenue for services associated with the equipment setup, provided it is part of the rent-to-own agreement.

Cash and Cash Equivalent

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of six months or less to be cash equivalents.

Loss per Share Calculations

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for employee options or warrants were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2013, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

Stock-Based Compensation

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

The fair value of the Company's common stock option grant is estimated using the Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2013:

	Total		(Level 1)		(Level 2)		(Level 3)
Other Asset
Investment	$	20,000	$	-	$	-	$	20,000
Total assets measured at fair value	$	20,000	$	-	$	-	$	20,000
Liabilities
Derivative Liability	$	2,677,675	$	-	$	-	$	2,677,675
Convertible Debenture, net of discount		1,318,266		-		-		1,318,266
Total liabilities measured at fair value	$	3,995,941	$	-	$	-	$	3,995,941

Use of Estimates

Use of Estimates

The preparation of the condensed financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

Reclassification

Reclassification

Certain expenses for the nine months ended September 30, 2012 were reclassified to agree with the classification for the current period.

Accounting for Derivatives

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies which instruments and transactions are subject to the offsetting disclosure requirements established by ASU 2011-11. This guidance is effective for annual and interim reporting periods beginning January 1, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other accounting pronouncements did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

XML

Statements Of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Sales	$ 40,500	$ 30,726	$ 140,500	$ 583,889
Cost of Goods Sold	19,866	13,543	50,510	420,906
Gross Profit	20,634	17,183	89,990	162,983
Operating Expenses
Selling and general and administrative expenses	1,689,260	1,310,532	3,349,921	4,024,066
Research and development	318,244	152,978	755,595	590,416
Total Operating Expenses	2,007,504	1,463,510	4,105,516	4,614,482
Loss before Depreciation and Amortization	(1,986,870)	(1,446,327)	(4,015,526)	(4,451,499)
Depreciation & amortization expense	4,508	3,401	11,263	10,203
Loss from Operations before Other Income/(Expenses)	(1,991,378)	(1,449,728)	(4,026,789)	(4,461,702)
OTHER INCOME/(EXPENSE)
Gain (Loss) on settlement of debt and extinguishment of derivative liability	2,446,467		2,310,953	(838,728)
Gain (Loss) on change in fair value of derivative liability	(1,343,167)	30,696	(3,543,781)	(14,716)
Fair value of discounted warrants	(645,398)		(704,575)
Commitment fee	(213,229)		(997,893)
Foreign exchange loss		(611)		(2,838)
Interest expense	(248,152)	(502,752)	(1,036,329)	(1,664,069)
TOTAL OTHER INCOME/(EXPENSE)	(3,479)	(472,667)	(3,912,448)	(2,520,351)
NET LOSS	$ (1,994,857)	$ (1,922,395)	$ (7,939,237)	$ (6,982,053)
BASIC DILUTED LOSS PER SHARE	$ (0.05)	$ (0.16)	$ (0.27)	$ (0.69)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	41,620,654	12,211,940	29,367,986	10,136,415

XML

Summary Of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as it is received, and the equipment has been fully accepted by the customer. Returns are based upon each rent-to-own agreement, and revenue would be adjusted based on a pro-rata basis on the unused months of quarterly payments. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have either a purchase agreement or rental agreement signed by the customer with a payment arrangement.  This is a critical policy, because we want our accounting to show only sales which have a final payment arrangement.

We also recognize revenue for services associated with the equipment setup, provided it is part of the rent-to-own agreement.

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of six months or less to be cash equivalents.

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for employee options or warrants were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2013, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

The fair value of the Company's common stock option grant is estimated using the Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2013:

	Total		(Level 1)		(Level 2)		(Level 3)
Other Asset
Investment	$	20,000	$	-	$	-	$	20,000
Total assets measured at fair value	$	20,000	$	-	$	-	$	20,000
Liabilities
Derivative Liability	$	2,677,675	$	-	$	-	$	2,677,675
Convertible Debenture, net of discount		1,318,266		-		-		1,318,266
Total liabilities measured at fair value	$	3,995,941	$	-	$	-	$	3,995,941

Use of Estimates

The preparation of the condensed financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

 Reclassification

Certain expenses for the nine months ended September 30, 2012 were reclassified to agree with the classification for the current period.

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies which instruments and transactions are subject to the offsetting disclosure requirements established by ASU 2011-11. This guidance is effective for annual and interim reporting periods beginning January 1, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other accounting pronouncements did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

XML

Summary Of Significant Accounting Policies (Detail Textuals)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]
Share based payments valuation method	Black Scholes option valuation model

XML

Summary Of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Schedule of fair value of financial instruments

	Total			(Level 1)			(Level 2)			(Level 3)
Other Asset
Investment		$	20,000		$	-		$	-		$	20,000
Total assets measured at fair value		$	20,000		$	-		$	-		$	20,000
Liabilities
Derivative Liability		$	2,677,675		$	-		$	-		$	2,677,675
Convertible Debenture, net of discount			1,318,266			-			-			1,318,266
Total liabilities measured at fair value		$	3,995,941		$	-		$	-		$	3,995,941

XML

Options And Warrants - Summary of shares authorized under stock option plans by exercise price range (Details 1) (USD $)				9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 Stock Options	Dec. 31, 2012 Stock Options	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 7.20	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 4.50	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 6.00	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 4.20	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 5.15	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 1.70	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.89	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.89	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.89	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.43	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.43	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.44	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.41	Sep. 30, 2013 Stock Options 2009 Plan, 2012 Plan, and 2013 Plan Exercisable Prices $ 0.38
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices		$ 0.57		$ 7.20	$ 4.50	$ 6.00	$ 4.20	$ 5.15	$ 1.70	$ 0.89	$ 0.89	$ 0.89	$ 0.43	$ 0.43	$ 0.44	$ 0.41	$ 0.38
Stock Options Outstanding	4,284,643	4,784,643	465,294	1,667	33,334	16,500	13,334	10,000	4,000	60,000	200,000	120,000	759,645	500,000	599,999	533,498	1,932,666
Stock Options Exercisable	1,563,696	1,208,696		1,261	15,451	10,431	6,530	4,685	1,750	18,719	58,230	32,439	759,645	500,000	35,508	4,677	114,370
Weighted Average Remaining Contractual Life (years)				1 year 11 months 23 days	2 years 1 month 24 days	2 years 2 months 23 days	2 years 9 months 15 days	2 years 10 months 17 days	3 years 4 days	8 years 9 months 4 days	8 years 10 months 2 days	8 years 11 months 5 days	9 years 6 months 15 days	9 years 9 months 4 days	9 years 11 months 16 days	9 years 11 months 16 days	9 years 11 months 16 days
Weighted Average Exercise Price of Options Outstanding				$ 0.46	$ 0.53	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36			$ 0.36
Weighted Average Exercise Price of Options Exercisable				$ 0.46	$ 0.53	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36	$ 0.36			$ 0.36

XML

Options And Warrants - Summary of company stock option activity (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options, outstanding, end of period	4,284,643
Number of Options, exercisable at the end of period	1,563,696
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options, outstanding, beginning of period	465,294
Number of Options, granted	4,325,808
Number of Options, exercised
Number of Options, forfeited/expired	(6,459)
Number of Options, outstanding, end of period	4,784,643
Number of Options, exercisable at the end of period	1,208,696
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, outstanding, beginning of period	$ 1.67
Weighted average exercise price, granted	$ 0.41
Weighted average exercise price, outstanding, end of period	$ 0.52
Weighted average exercise price, exercisable at the end of period	$ 0.57
Weighted average fair value of options granted during the period	$ 0.41

XML

Derivative Liabilities (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Derivative Liabilities (Textual)
Fair value of derivative liabilities	$ 2,677,675		$ 2,677,675		$ 355,526
Debt conversion converted amount			1,851,786
Gain on extinguishment of debt	2,446,467		2,310,953	(838,728)
Gain (Loss) on change in fair value of derivative liability	(1,343,167)	30,696	(3,543,781)	(14,716)
Derivative liabilities [Member]
Derivative Liabilities (Textual)
Fair value of derivative liabilities	2,677,675		2,677,675
Aggregate amount of fair value liabilities	2,033,406		2,033,406
Notes payable derivative liabilities	1,580,000		1,580,000
Changes in derivative liability			453,406
Debt conversion converted amount			779,208
Gain on extinguishment of debt			2,310,953
Gain (Loss) on change in fair value of derivative liability			3,543,781
Convertible notes issuance	$ 2,033,406		$ 2,033,406

XML

Unsecured Promissory Notes (Detail Textuals) (USD $)	1 Months Ended	9 Months Ended
	Jan. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
Short-term Debt [Line Items]
Converted aggregate principal amount of promissory note		$ 1,851,786
January 2012 Unsecured Convertible Promissory Note
Short-term Debt [Line Items]
Gross proceeds from unsecured debt	1,669,828
Debt instrument interest rate	8.00%
Unsecured promissory note payment term	The January 2012 Notes were also redeemable by the Company, at the holder's option, at maturity at a redemption price of 112% of the outstanding principal plus accrued and unpaid interest.
Aggregate principal amount outstanding		0	210,000
Common stock shares issued		494,020
Converted aggregate principal amount of promissory note		200,000
Upfront shares issued in debt conversion		247,010
Fair value of upfront shares issued in debt conversion		123,946
Balance paid in cash		10,000
Options grant date	The notes matured in one year	The January 2012 Notes had an aggregate remaining principal amount of $210,000, which expired in January 2013.
Gain loss on settlement of debt		123,946
Convertible Promissory Note
Short-term Debt [Line Items]
Converted aggregate principal amount of promissory note		200,000
Fair value of upfront shares issued in debt conversion		$ 123,946

XML

Capital Stock (Detail Textuals) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Capital Stock [Line Items]
Number of warrants exercised	454,911
Number of cash warrants exercised	478,912
Common stock value for purchase warrants at fair value through a cash exercise	$ 119,729
Proceeds for issuance of common stock	2,387,271	808,896
Aggregate principal original issue debt	1,851,786
Convertible Promissory Note
Capital Stock [Line Items]
Upfront shares issued for notes payable	123,946
Aggregate principal original issue debt	200,000
Interest on note	16,134
Convertible Promissory Note Two
Capital Stock [Line Items]
Gain on derivative	1,527,840
Warrant
Capital Stock [Line Items]
Common stock value for purchase warrants at fair value through a cash exercise	478,912
One Year Warrants
Capital Stock [Line Items]
Number of common stock called by warrants at first closing (in shares)	13,192,750
Three Year Warrants
Capital Stock [Line Items]
Number of common stock called by warrants at first closing (in shares)	11,762,547
Five Year Warrants
Capital Stock [Line Items]
Number of common stock called by warrants at first closing (in shares)	17,230,775
Minimum
Capital Stock [Line Items]
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.31
Minimum | Warrant
Capital Stock [Line Items]
Exercise price of warrants (in dollars per share)	0.15
Maximum
Capital Stock [Line Items]
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.63
Maximum | Warrant
Capital Stock [Line Items]
Exercise price of warrants (in dollars per share)	0.25
Common stock
Capital Stock [Line Items]
Common stock shares issued for settlement of a convertible promissory note	10,017,216
Common stock issued for services (in shares)	1,991,198
Common stock issued for purchase warrants at fair value through a cash exercise	478,912
Common stock issued with for settlement of debt at fair value (in shares)	10,511,236
Common stock shares issued	494,020
Number of common stock called by warrants at first closing (in shares)	12,270,172
Proceeds for issuance of common stock	2,267,542
Aggregate principal original issue debt	$ 1,051
Common stock | Convertible Promissory Note
Capital Stock [Line Items]
Common stock issued with for settlement of debt at fair value (in shares)	247,010
Upfront shares issued in debt conversion	247,010
Common stock | Minimum
Capital Stock [Line Items]
Conversion price	$ 0.11
Exercise price of warrants (in dollars per share)	0.12
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.31
Common stock | Maximum
Capital Stock [Line Items]
Conversion price	$ 0.875
Exercise price of warrants (in dollars per share)	0.25
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.63

XML

Statement Of Shareholders' Deficit (Unaudited) (Parentheticals) (USD $)	9 Months Ended
	Sep. 30, 2013
Issue price of common stock issued for purchase warrants (in dollars per share)	$ 0.25
Minimum
Issue price of common stock issued for cash (in dollars per share)	$ 0.125
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.31
Issue price of common stock issued for conversion of debt (in dollars per share)	$ 0.11
Maximum
Issue price of common stock issued for cash (in dollars per share)	$ 0.25
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.63
Issue price of common stock issued for conversion of debt (in dollars per share)	$ 0.875
Common stock | Minimum
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.31
Common stock | Maximum
Issue price of common stock issued for services at fair value (in dollars per share)	$ 0.63

XML

Supplemental Disclosures Of Non Cash Transactions (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Conversion of accounts payable into a long term convertible note		$ 290,560
Extinguishment of fair value of derivative liability		1,378,774
Beneficial conversion		161,422
Fair Value of options issued to officer in prior year		209,000
Common stock issued for conversion of notes	$ 851,089	$ 1,851,786

XML

Capital Stock

9 Months Ended

Sep. 30, 2013

Capital Stock [Abstract]

CAPITAL STOCK

3.  CAPITAL STOCK

During the nine months ended September 30, 2013, the Company issued 1,991,198 shares of common stock for services with prices ranging from $0.25 up to $0.63 with a total fair value of $793,751.  The shares issued were valued at the trading price at the date of the agreement.

During the nine months ended September 30, 2013, the Company issued 494,020 shares of common stock of which 247,010 shares were associated with the settlement of a convertible promissory note for principal in the amount of $200,000 and interest in the amount of $16,134, and additional shares of 247,010 as an inducement to convert issued with the notes with a fair value of $123,946 based upon the trading price of our common stock at the date of the agreement.

During the nine months ended September 30, 2013, the Company issued 10,017,216 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $1,527,840 based upon a conversion price of $0.11 up to $0.875.

During the nine months ended September 30, 2013, the Company issued 332,960 shares of common stock in exchange for a cashless exercise of 454,911 purchase warrants.

During the nine months ended September 30, 2013, the Company issued 478,912 shares of common stock upon exercise of the purchase warrants in the amount of 478,912 for cash in the amount of $119,729.

During the nine months ended September 30, 2013, the Company received proceeds for issuance of common stock for cash of $2,267,542 for the purchase of 12,270,172 shares of common stock at prices per share ranging from $0.12 to $0.25.  Included in the purchase are one-year warrants to purchase an aggregate of 13,192,750 shares of common stock, three-year warrants to purchase an aggregate of 11,762,547 shares of common stock and five-year warrants to purchase an aggregate of 17,230,775 shares of common stock. Each warrant is exercisable at a price per share between $0.15 up to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like.

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2013

Basis Of Presentation [Abstract]

Basis of Presentation

 1.   Basis of Presentation

The accompanying unaudited condensed financial statements of OriginOil, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included.  Operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.  For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2012.

Going Concern

The accompanying condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying condensed financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the nine months ended September 30, 2013, the Company did not generate significant revenue, incurred a net loss of $7,939,237 and cash used in operations of $2,989,484.  As of September 30, 2013, the Company had a working capital deficiency of $2,709,557 and a shareholders’ deficit of $2,149,051.   These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern.  Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2012 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders in the nine months ended September 30, 2013, and has standing purchase orders and open invoices with customers. Management believes this funding will continue from its’ current investors and has also obtained funding from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations.

XML

Options And Warrants - Summary of company warrants activity (Details 2) (USD $)	9 Months Ended
	Sep. 30, 2013
Class Of Warrant Or Right [Roll Forward]
Warrants, outstanding - end of period	42,699,397
Warrant
Class Of Warrant Or Right [Roll Forward]
Warrants, outstanding -beginning of period	7,098,104
Warrants, granted	37,883,896
Warrants, exercised	(933,824)
Warrants, forfeited	(857,805)
Warrants, outstanding - end of period	43,190,371
Class Of Warrant Or Right, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, outstanding - beginning of year	$ 0.79
Weighted average exercise price, granted	$ 0.20
Weighted average exercise price, exercised	$ 0.30
Weighted average exercise price, forfeited	$ 1.26
Weighted average exercise price, outstanding - end of year	$ 0.31

XML

Convertable Promissory Notes (Detail Textuals) (USD $)	3 Months Ended		9 Months Ended			9 Months Ended					1 Months Ended	9 Months Ended			0 Months Ended		9 Months Ended		0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	12 Months Ended	1 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Sep. 30, 2013 Minimum	Sep. 30, 2013 Maximum	Sep. 30, 2013 Common Stock [Member]	Sep. 30, 2013 Common Stock [Member] Minimum	Sep. 30, 2013 Common Stock [Member] Maximum	Mar. 31, 2013 March 2013 Convertible Promissory Notes [Member]	Sep. 30, 2013 March 2013 Convertible Promissory Notes [Member]	Mar. 31, 2013 March 2013 Convertible Promissory Notes [Member] Minimum	Mar. 31, 2013 March 2013 Convertible Promissory Notes [Member] Maximum	May 21, 2013 May 2013 Convertible Promissory Notes [Member]	May 28, 2013 May 2013 Convertible Promissory Notes [Member]	Sep. 30, 2013 May 2013 Convertible Promissory Notes [Member]	May 31, 2013 May 2013 Convertible Promissory Notes [Member]	Jul. 16, 2013 July 2013 Convertible Promissory Note [Member]	Sep. 30, 2013 July 2013 Convertible Promissory Note [Member]	Aug. 28, 2013 August 2013 Convertible Promissory Notes [Member]	Sep. 30, 2013 August 2013 Convertible Promissory Notes [Member]	Sep. 27, 2013 September 2013 Convertible Promissory Notes [Member]	Sep. 30, 2013 September 2013 Convertible Promissory Notes [Member]	Dec. 31, 2012 September 2013 Convertible Promissory Notes [Member]	Jun. 20, 2012 Securities Purchase Agreement June 2012 Convertible Promissory Notes [Member]	Sep. 30, 2013 Securities Purchase Agreement June 2012 Convertible Promissory Notes [Member]	Feb. 15, 2013 Securities Purchase Agreement June 2012 Convertible Promissory Notes [Member]
Short-term Debt [Line Items]
Proceeds from initial advance for issuance of note			$ 1,580,000									$ 235,000														$ 100,000,000
Aggregate principal amount debt											665,000				290,560	255,000		125,000	255,000		255,000		255,000			400,000
Note bears interest rate																10.00%		10.00%	10.00%		10.00%		10.00%			10.00%
Number of common stock called by warrants (in shares)																										615,384
Exercise price of warrants (in dollars per share)									0.12	0.25																0.65
Number of common stock called by warrants at first closing (in shares)								12,270,172																		153,846
Unsecured convertible promissory issued											221,665															300,000
Accrued interest																										15,000
Number of common stock called by warrants receive further (in shares)																										461,358
Increased interest rate																										15.00%
Percentage of average of lowest closing prices															75.00%	50.00%
Term of warrants						6 months	4 years
Number of trading days previous to conversion															25 days											25 days
Total amount funded																										300,000		100,000
Unused remaining principal balance																124,208	255,000	125,000		255,000			453,406	255,000		175,792
Aggregate principal original issue discount, accrued interest and extension fees			1,851,786					1,051												203,346				779,208
Discount on debt (in dollars)								1,371,658			78,333										2,310,953
Conversion price of convertible debentures									$ 0.11	$ 0.875			$ 0.4375	$ 0.65				$ 0.40	$ 0.35		$ 0.30		$ 0.35
Term of note maturity											90 days
One time interest charge											31,332										3,543,781
Extension period of maturity on repayment of notes											30 days
Percentage of extension fee											25.00%
Interest and extension fee amount												601,562
Derivative liability	2,677,675		2,677,675		355,526
Conversion price per share of debt, Description																The note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.45 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.			The note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note		The note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.35 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.		The note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note
Maturity term of debt																6 months			9 months		9 months		9 months
Interest Expense	248,152	502,752	1,036,329	1,664,069												8,663	5,205			5,310		2,305		210			30,000
Amortization of debenture discount			22,335																					727,562	276,604
Beneficial conversion features			$ 161,422

XML

Subsequent Events (Detail Textuals 2) (USD $)	9 Months Ended
	Sep. 30, 2013
Subsequent Event [Line Items]
Common stock value of shares issued for services	$ 793,751
Common stock
Subsequent Event [Line Items]
Common stock issued for services (in shares)	1,991,198
Common stock value of shares issued for services	199
Subsequent Event | Common stock
Subsequent Event [Line Items]
Common stock issued for services (in shares)	243,016
Common stock value of shares issued for services	$ 72,374

XML

Balance Sheets (Parentheticals) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	43,552,023	17,967,545
Common stock, shares outstanding	43,552,023	17,967,545
Convertible promissory notes
Discount on debt (in dollars)	$ 727,562	$ 237,965
Unsecured notes payable
Discount on debt (in dollars)	0	38,639
Convertible Promissory Note
Discount on debt (in dollars)	$ 139,087

XML

Convertable Promissory Notes

9 Months Ended

Sep. 30, 2013

Convertible Promissory Notes [Abstract]

CONVERTIBLE PROMISORY NOTES

6. CONVERTIBLE PROMISSORY NOTES

June 2012 Convertible Promissory Notes

On June 20, 2012, the Company received an initial advance of $100,000 in consideration for the issuance of a note in the principal amount of $400,000 on a securities purchase agreements entered into for the sale of a 10% convertible promissory note, with an aggregate sum of $400,000, plus warrants to purchase an aggregate of up to 615,384 shares of the Company’s common stock at a purchase price of $0.65 per share. At closing, which took place simultaneously with execution of the securities purchase agreement, the Company issued the note with an outstanding principal sum of $100,000 together with a warrant to purchase 153,846 shares of the Company’s common stock. Under the terms of the securities purchase agreement, the investor had the option to advance an additional $300,000 in principal under the note and receive further warrants to purchase an aggregate of up to 461,538 shares of the Company’s common stock. The note originally matured six months from the date of each purchase made under the note, and bore interest at a rate of 10% per annum, which increased to 15% when the note was not repaid by September 18, 2012. The Note was originally convertible into shares of the Company’s common stock at a conversion price of $0.65. The warrants may be exercised at any time for a period of four years from the date of issuance at an exercise price of $0.65.

On February 15, 2013, the Company and the lender entered into an amendment to the note providing for, among other things, an extension of the maturity date of the note until July 21, 2013 and the amendment of the conversion price of the note to the lesser of $0.65 or 70% of the average of the three lowest closing prices in the 25 trading days previous to a conversion., During the month of June, 2013, the lender advanced another $100,000 under the securities purchase agreement, bringing the total outstanding principal due under the note to $300,000. Simultaneous therewith, the Company issued to the lender a warrant to purchase 153,846 shares of the Company's common stock. During the nine months ended September 30, 2013, the lender converted $124,208 of the convertible notes, plus accrued interest of $15,000, leaving a remaining principal balance of $175,792. During the nine months ended September 30, 2013, the Company recognized interest expense of $30,000.

        March 2013 Convertible Promissory Notes

As of March 31, 2013, the Company had issued convertible promissory notes to various investors in an aggregate principal amount of $665,000 with an original issue discount of $221,665.  The convertible notes were originally convertible into the common stock of the Company at conversion prices ranging from $0.4375 to $0.65.  As a result of most favored nations protection accorded to the convertible notes, the conversion price of the convertible notes is the lesser of $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price of common stock on any trading day after issuance of the convertible notes. The maturity dates of the notes are ninety (90) days from their effective date, with a one-time aggregate interest charge of $31,332, which will be amortized over ninety (90) days and recorded as interest expense.  If the convertible notes are not repaid on maturity, then the maturity date shall be automatically extended for up to three further 30 day periods and an extension fee of 25% of the then outstanding principal, interest and other fees shall be added to the principal amount of the notes at the end of each 30 day period that the convertible notes are still outstanding.  The convertible notes issued in February and March, 2013, to various investors in an aggregate principal amount of $235,000, with an aggregate original issue discount of $78,333, provide that for as long as the convertible notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the convertible notes or such other convertible notes or a term was not similarly provided to the purchaser of the convertible notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the convertible notes and such other convertible notes.

During the nine months ended September 30, 2013, the lenders converted principal of $405,000 plus original issue discount of 201,667, accrued interest and extension fees for an aggregate amount of $764,991. As of September 30, 2013, the remaining principal balance plus the original issue discount, accrued interest and fees was $601,562.

May 2013 Convertible Promissory Notes

On May 1, 2013, the Company issued convertible notes in an aggregate principal amount of $125,000.The notes mature six (6) months from the date of issuance and bear interest at 10% per annum. The notes may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the notes.  The Company has the right to enforce a conversion floor price of $0.40 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013 the remaining principal balance was $125,000. During the nine months ended September 30, 2013, the Company recognized interest expense of $5,205.

On May 21, 2013, the Company entered into a convertible promissory note for the payment of an accounts payable in the amount of $290,560. The note bears no interest and matures on December 31, 2015. The Company may pay the note in full on or before the maturity date without penalty. The note may be converted into common shares of the Company’s common stock at a conversion price of 75% of the average lowest three (3) last sale prices during the 25 trading days immediately preceding the date of delivery. As the conversion price of the note was less than the market price of the Company common stock at the date of its issuance, the Company determined that the note contained a beneficial conversion feature of 161,422. The note’s beneficial conversion feature is  considered as debt discount and is being amortized over the life of the Note. Amortization of debt discount for the nine months ended September 30, 2013 was $22,335.

On May 28, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures six (6) months from the date of issuance and bears interest at 10% per annum. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.45 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.40 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance was $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $8,663.

July 2013 Convertible Promissory Note

On July 16, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured, and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.35 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $5,310.

August 2013 Convertible Promissory Notes

On August 28, 2013, the Company issued convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.35 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.30 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the notes or such other convertible notes or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the notes and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $2,305.

September 2013 Convertible Promissory Notes

On September 27, 2013, the Company issued a convertible note with an aggregate principal amount of $255,000.The note is unsecured and matures nine (9) months from the date of issuance and bears interest at 10% per annum. At the sole option of the lender, the lender may modify the maturity date to be twelve (12) months from the effective date. The note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.40 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the note.  The Company has the right to enforce a conversion floor price of $0.35 per share. If the Company elects to enforce the conversion floor price, then the lender will incur a conversion loss, which the Company must make whole by paying the amount of the conversion loss by cash payment, and any such cash payment must be made by the third day from the time of the conversion notice. The notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, for as long as the note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the note or such other convertible note or a term was not similarly provided to the purchaser of the note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the note and such other convertible notes. As of September 30, 2013, the remaining principal balance of $255,000 was still outstanding. During the nine months ended September 30, 2013, the Company recognized interest expense of $210.

The agreements governing the Convertible Notes discussed above, excluding the convertible note date May 21, 2013 of $290,560, includes an anti-dilution provision that allows for the automatic reset of the conversion price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the current conversion price of the Amended Notes or exercise price of the warrants issued with the Convertible Notes. The Company considered the current FASB guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that the conversion price of the Convertible Notes are not a fixed amount because they are subject to fluctuation based on the occurrence of future offerings or events. As a result, the Company determined that the conversion features are not considered indexed to the Company’s own stock and characterized the initial fair value of these warrants as derivative liabilities upon issuance. The Company determined the aggregate initial fair value of the embedded beneficial conversion feature of the Conversion Notes issued during the period ended September 30, 2013 to be $2,033,406. These amounts were determined by management with the use of weighted average Black-Scholes Merton option pricing model. As such, the Company recorded a$1,371,705 valuation discount upon issuance of the notes. The Company is amortizing this valuation discount to interest expense over the life of the notes. During the nine month ended September 30, 2013 the Company included in interest relating to the amortization of this discount, and as of September 30, 2013 and December 31, 2012, the unamortized balance of the note discount was $727,562 and $276,604, respectively.

XML

Statement Of Shareholders' Deficit (Unaudited) (USD $)	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2012		$ 1,797	$ 27,024,419	$ (27,567,112)	$ (540,896)
Balance (in shares) at Dec. 31, 2012		17,967,545
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued at prices of $0.125 and $0.25 per share for cash		1,227	2,266,315		2,267,542
Common stock issued at prices of $0.125 and $0.25 per share for cash (in shares)		12,270,172
Common stock issued for services at fair value ranging in prices between $0.31 and $0.63		199	793,552		793,751
Common stock issued for services at fair value ranging in prices between $0.31 and $0.63 (in shares)		1,991,198
Common stock issued for conversion of debt (prices per share of $0.11 and $0.875)		1,051	1,850,735		1,851,786
Common stock issued for conversion of debt (prices per share of $0.11 and $0.875) (in shares)		10,511,236
Common stock issued upon exercise of warrants at fair value through a cashless exercise		33	(33)
Common stock issued upon exercise of warrants at fair value through a cashless exercise (in shares)		332,960
Common stock issued for warrants at $0.25 per share for cash		48	119,681		119,729
Common stock issued for warrants at $0.25 per share for cash (in shares)		478,912
Fair Value Adjustment of Warrants			645,398		704,575
Beneficial conversion feature on note			161,422		161,422
Stock and warrant compensation cost			432,277		432,277
Net loss for the nine months ended September 30, 2013				(7,939,237)	(7,939,237)
Balance at Sep. 30, 2013		$ 4,355	$ 33,352,943	$ (35,506,349)	$ (2,149,051)
Balance (in shares) at Sep. 30, 2013		43,552,023

XML

Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
CURRENT ASSETS
Cash	$ 1,298,576	$ 507,355
Accounts receivable	20,000	25,000
Work in process	64,600	35,666
Prepaid expenses	121,167	186,978
Other receivables		1,200
TOTAL CURRENT ASSETS	1,504,343	756,199
PROPERTY & EQUIPMENT
Machinery & equipment	76,794	32,670
Furniture & fixtures	27,056	27,056
Computer equipment	29,789	28,824
Leasehold improvements	94,914	94,914
GROSS PROPERTY & EQUIPMENT	228,553	183,464
Less accumulated depreciation	(151,330)	(140,067)
NET PROPERTY & EQUIPMENT	77,223	43,397
OTHER ASSETS
Investment	20,000	20,000
Patents	449,166	317,689
Trademark	4,467	4,467
Security deposit	9,650	9,650
TOTAL OTHER ASSETS	483,283	351,806
TOTAL ASSETS	2,064,849	1,151,402
Current Liabilities
Accounts payable	42,395	353,200
Accrued expenses	175,564	376,846
Derivative liability	2,677,675	355,526
Convertible promissory notes, net of discount of $866,649 and 237,965, respectively	1,166,793	435,365
Unsecured notes payable, net of discount of $0 and $38,639, respectively		171,361
Total Current Liabilities	4,062,427	1,692,298
Long Term Liabilities [Abstract]
Convertible note payable, net of discount of $139,087	151,473
Total Long Term Liabilities	151,473
TOTAL LIABILITIES	4,213,900	1,692,298
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 25,000,000 authorized preferred shares
Common stock, $0.0001 par value; 250,000,000 authorized common shares 43,552,023 and 17,967,545 shares issued and outstanding	4,355	1,797
Additional paid in capital	33,352,943	27,024,419
Accumulated deficit	(35,506,349)	(27,567,112)
TOTAL SHAREHOLDERS' DEFICIT	(2,149,051)	(540,896)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 2,064,849	$ 1,151,402

XML

Options And Warrants - Summary of shares authorized under warrants by exercise price range (Details 3)						9 Months Ended																													9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 Warrant	Dec. 31, 2012 Warrant	Sep. 30, 2013 Warrant Maximum	Sep. 30, 2013 Warrant Minimum	Sep. 30, 2013 Warrant Exercisable Prices $ 9.30	Sep. 30, 2013 Warrant Exercisable Prices $ 10.20	Sep. 30, 2013 Warrant Exercisable Prices $ 9.00	Sep. 30, 2013 Warrant Exercisable Prices $ 8.70	Sep. 30, 2013 Warrant Exercisable Prices $ 8.40	Sep. 30, 2013 Warrant Exercisable Prices $ 8.70	Sep. 30, 2013 Warrant Exercisable Prices $ 5.70	Sep. 30, 2013 Warrant Exercisable Prices $ 4.50	Sep. 30, 2013 Warrant Exercisable Prices $ 4.20	Sep. 30, 2013 Warrant Exercisable Prices $ 4.20	Sep. 30, 2013 Warrant Exercisable Prices $ 3.60	Sep. 30, 2013 Warrant Exercisable Prices $ 4.50	Sep. 30, 2013 Warrant Exercisable Prices $ 4.20	Sep. 30, 2013 Warrant Exercisable Prices $ 6.00	Sep. 30, 2013 Warrant Exercisable Prices $ 6.00	Sep. 30, 2013 Warrant Exercisable Prices $ 6.30	Sep. 30, 2013 Warrant Exercisable Prices $ 5.70	Sep. 30, 2013 Warrant Exercisable Prices $ 6.90	Sep. 30, 2013 Warrant Exercisable Prices $ 6.90	Sep. 30, 2013 Warrant Exercisable Prices $ 1.90	Sep. 30, 2013 Warrant Exercisable Prices $ 6.90	Sep. 30, 2013 Warrant Exercisable Prices $1.47	Sep. 30, 2013 Warrant Exercisable Prices $0.65	Sep. 30, 2013 Warrant Exercisable Prices $0.65	Sep. 30, 2013 Warrant Exercisable Prices $0.65 Maximum	Sep. 30, 2013 Warrant Exercisable Prices $0.65	Sep. 30, 2013 Warrant Exercisable Prices 0.25	Sep. 30, 2013 Warrant Exercisable Prices $ 0.89	Sep. 30, 2013 Warrant Exercisable Prices $ 0.15 - 0.65	Sep. 30, 2013 Warrant Exercisable Prices $ 0.15 Minimum	Sep. 30, 2013 Warrant Exercisable Prices 0.25	Sep. 30, 2013 Warrant Exercisable Prices 0.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices				0.25	0.15	9.30	10.20	9.00	8.70	8.40	8.70	5.70	4.50	4.20	4.20	3.60	4.50	4.20	6.00	6.00	6.30	5.70	6.90	6.90	1.90	6.90	1.47	0.65	0.65	0.65	0.65	0.25	0.89		0.15	0.25	0.25
Warrants Outstanding	42,699,397	43,190,371	7,098,104			223,338	28,335	9,168	3,334	667	5,000	7,334	3,334	8,334	33,334	8,334	33,334	13,335	133,334	33,334	8,334	4,001	33,334	33,334	80,000	33,334	260,000	80,000	20,000		50,000	124,000	100,000	41,127,610		250,000	47,500
Warrants Exercisable	42,938,833					223,338	28,335	9,168	3,334	667	5,000	7,334	3,334	8,334	33,334	8,334	33,334	13,335	133,334	33,334	8,334	4,001	33,334	33,334	80,000	33,334	260,000	80,000	20,000		50,000	124,000	100,000	41,512,493		47,500	8,654
Weighted Average Remaining Contractual Life (years)						9 months	10 months 17 days	1 year 22 days	1 year 1 month 13 days	1 year 3 months 29 days	1 year 7 months 28 days	1 year 10 months 2 days	1 year 11 months 12 days	1 year 11 months 23 days	1 year 11 months 27 days	2 years 3 months 29 days	2 years 29 days	2 years 1 month 28 days	2 years 2 months 27 days	2 years 2 months 23 days	2 years 5 months 19 days	2 years 6 months	2 years 8 months 16 days	2 years 11 months 16 days	3 years 4 days	3 years 2 months 16 days	3 years 6 months 26 days	3 years 10 months 10 days	4 years 18 days	4 years 8 months 12 days	4 years 29 days	4 years 6 months	9 years 1 month 17 days		4 days	4 years 9 months 15 days	4 years 11 months 19 days

XML

Summary Of Significant Accounting Policies - Summary of assets and liabilities measured at fair value on recurring basis (Details) (Fair Value, Measurements, Recurring, USD $)	Sep. 30, 2013
Total
Other Asset
Investment	$ 20,000
Total assets measured at fair value	20,000
Liabilities
Derivative Liability	2,677,675
Convertible Debenture, net of discount	1,318,266
Total liabilities measured at fair value	3,995,941
(Level 1)
Other Asset
Investment
Total assets measured at fair value
Liabilities
Derivative Liability
Convertible Debenture, net of discount
Total liabilities measured at fair value
(Level 2)
Other Asset
Investment
Total assets measured at fair value
Liabilities
Derivative Liability
Convertible Debenture, net of discount
Total liabilities measured at fair value
(Level 3)
Other Asset
Investment	20,000
Total assets measured at fair value	20,000
Liabilities
Derivative Liability	2,677,675
Convertible Debenture, net of discount	1,318,266
Total liabilities measured at fair value	$ 3,995,941

XML

Subsequent Events (Detail Textuals ) (USD $)	1 Months Ended			9 Months Ended		1 Months Ended
	Oct. 23, 2013	Oct. 28, 2013	Oct. 23, 2013 Warrant [Member]	Sep. 30, 2013 Common stock	Sep. 30, 2013 Common stock Convertible Promissory Note	Oct. 23, 2013 Subsequent Event Convertible Promissory Note Original Issuance Discount Promissory Notes	Nov. 01, 2013 Subsequent Event Convertible Promissory Note Original Issuance Discount Promissory Notes	Nov. 01, 2013 Subsequent Event Common stock
Subsequent Event [Line Items]
Number of shares purchased for options awarded								1,221,408
Aggregate purchase price of common stock	$ 38,481	$ 90,792
Common stock issued with for settlement of debt at fair value (in shares)				10,511,236	247,010	2,931,214
Converted principal,fees and interest amount of promissory note						$ 315,105	$ 131,301
Aggregate Purchase Price Of Common Stock Shares	153,922	551,507	154,924
Aggregate Purchase Price Of Common Stock Per Shares	$ 0.25

XML

Subsequent Events (Detail Textuals 1) (Subsequent Event, Convertible Promissory Note, USD $)	0 Months Ended
	Oct. 30, 2013
Subsequent Event | Convertible Promissory Note
Subsequent Event [Line Items]
Aggregate principal amount debt	$ 255,000
Maturity term of debt	6 months
Debt instrument interest rate	10.00%
Conversion price per share of debt, Description	conversion price of the lesser of $0.30 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Note.
Percentage of outstanding principal and accrued interest on debt for rapayment of mandatory default amount in cash	150.00%

XML

Unsecured Promissory Notes

9 Months Ended

Sep. 30, 2013

Unsecured Debt [Abstract]

UNSECURED PROMISSORY NOTES

5.           UNSECURED PROMISSORY NOTES

In January 2012, the Company issued its “January 2012 Notes” for gross proceeds of $1,669,828.  The notes matured in one year upon issuance, accrued interest at 8% per annum and were payable on the conversion date and/or at maturity. The January 2012 Notes were also redeemable by the Company, at the holder’s option, at maturity at a redemption price of 112% of the outstanding principal plus accrued and unpaid interest. At December 31, 2012, the January 2012 Notes had an aggregate remaining principal amount of $210,000.

During the period ended September 30, 2013, the Company issued 494,020 shares of common stock in conversion of a principal amount of $200,000, with 247,010 upfront shares for a fair value of $123,946. The remaining $10,000 was paid in cash to the holder.  As a result of the settlement, the Company recognized a loss of $123,946 to account for the fair value of the shares of common stock issued which was recorded as part of the gain and loss on settlement of debt in the accompanying Statement of Operations.

The aggregate principal amount outstanding at September 30, 2013 was $0.

XML

Options And Warrants (Detail Textuals) (USD $)

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Warrant

Sep. 30, 2013

Maximum

Warrant

Sep. 30, 2013

Minimum

Warrant

Sep. 30, 2013

2009 Incentive Stock Option Plan

Sep. 30, 2013

Stock option plan

May 31, 2012

Stock option plan

Sep. 30, 2013

2013 Incentive Stock Option Plan

Sep. 30, 2013

2013 Plan

Sep. 30, 2013

2013 Plan

Maximum

Sep. 30, 2013

2013 Plan

Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock shares reserves and sets aside for the granting of options (in shares)

500,000

1,000,000

4,000,000

Exercise period of stock option exercisable

10 years

10 years

Determination of exercise price by holders percentage description

If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant.

Vest monthly after 90 days from grant ate over a period of five (5) years

Employee Termination

not less than 30 days nor more than three (3) months after such termination

Non-Statutory stock options

2,532,665

Vested Term

5 years

5 years

5 years

Granted options

37,427,384

533,498

500,000

Options exercisable price, per share

$ 0.25

$ 0.15

$ 0.41

$ 0.29

$ 0.44

$ 0.38

Estimated fair value of option

$ 122,705

$ 700,000

$ 582,513

Share based compensation expense

117,729

1,076

70,000

34,472

Future unamortized compensation expense

961,818

Proceeds from issuance of warrants

$ 811,872

Common stock issued upon exercise of warrants at fair value through a cashless exercise (in shares)

933,824

Option to purchase shares to officer

759,645

Shares issued, price per share

$ 0.43

XML

Subsequent Events

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

8.   SUBSEQUENT EVENTS

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following:

Between October 1, 2013 and October 28, 2013, a Lender under a prior securities purchase agreement, converted an aggregate principal and interest amount of $90,792 into an aggregate of 551,507 shares of the Company’s common stock.

Between October 1, 2013 and October 29, 2013, holders of original issuance discount convertible promissory notes issued between December 2012 and March 2013 in the aggregate principal, fees and interest amount of $315,105, converted the notes in full into an aggregate of 2,931,214 shares of the Company’s common stock.

Between October 7, 2013 and October 23, 2013, holders of warrants to purchase up to an aggregate of 154,924 shares of the Company’s common stock at an exercise price of $0.25 per share delivered notices of election to partially exercise the warrants on a cash basis resulting in the issuance of 153,922 shares of the Company’s common stock for an aggregate purchase price of $38,481.

On October 30, 2013, the Company issued a Convertible Note (“Note”) with an aggregate principal amount of $255,000. The Note matures nine (9) months from the date of issuance and bears interest at 10% per annum. The Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.30 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Note.  The Note includes customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default under the Note, the Company shall be required to repay a mandatory default amount in cash equal to 150% of the outstanding principal amount of the Note plus accrued and unpaid interest and other fees due thereon and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Note or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Note or such other convertible notes or a term was not similarly provided to the purchaser of the Note or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Note and such other convertible notes.

On November 1, 2013, holders of convertible promissory notes issued in May 2013 in the aggregate principal and interest amount of $131,301, converted the notes in full into an aggregate of 1,221,408 shares of the Company’s common stock.

During the subsequent period, the Company issued 243,016 shares of common stock for services at fair value of $72,374.

XML

Options and Warrants

9 Months Ended

Sep. 30, 2013

Stocks and Warrants [Abstract]

OPTIONS AND WARRANTS

4. OPTIONS AND WARRANTS

Options

The Board of Directors adopted the OriginOil, Inc., 2009 Incentive Stock Option Plan (the “2009 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Five Hundred Thousand (500,000) shares of Common Stock.  

On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc., 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for One Million (1,000,000) shares of Common Stock.  Options granted under these Plans may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc., 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Four Million (4,000,000) shares of Common Stock.  Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the Optionee or their representative shall have the right to exercise the portion of any Options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

With respect to Non-statutory Options granted to employees, directors or consultants, the Board or Committee may specify such period for exercise that the Option shall automatically terminate following the termination of employment or services as to shares covered by the Option as the Board or Committee deems reasonable and appropriate.

During the nine months ended September 30, 2013, the Company granted 533,498 incentive stock options to employees with an estimated fair value of approximately $122,705 using the Black-Scholes-Merton calculation. The options are exercisable at $0.41/share, vest monthly after 90 days from grant date over a period of five (5) years and expire in ten (10) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $1,076 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company granted 2,532,665 Non-statutory stock options under the 2013 Stock Option Plan to employees and board of directors with an estimated fair value of approximately $582,513 using the Black-Scholes-Merton calculation. The options are exercisable at $0.38/share up to $0.44/share, vest over a period of five (5) and expire in ten (10) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $34,472 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company granted 500,000 options under the 2013 Stock Option Plan to an employee with an estimated fair value of approximately $70,000 using the Black-Scholes-Merton calculation. The options are exercisable at $0.29/share, vest immediately and expire in five (5) years from the date of grant. During the period ended September 30, 2013, the Company recognized compensation costs of $70,000 based on the fair value of options that vested.

During the nine months ended September 30, 2013, the Company recorded $117,729 of compensation cost based on the vesting of the options granted to employees, directors and consultants in prior periods. Future unamortized compensation expense on the unvested outstanding options at September 30, 2013 is approximately $961,818.

In fiscal 2012, the Board of Directors agreed to grant an officer of the Company options to purchase 759,645 shares of common stock at $0.43 per share.  Upon grant, the options vested immediately and will expire in 5 years.  Total fair value of the options granted amounted $209,000 determined using the Black-Scholes Option Pricing Model and was recorded in 2012 and reflected in compensation cost and as due to officer which is included as part of Accrued Expenses in the accompanying Balance Sheet.  In April 2013, the Board formally approved the issuance of the 759,645 options and the amount was reclassified from due to officer to Additional Paid in Capital.

A summary of the Company’s stock option activity and related information follows:

	September 30, 2013
				Weighted
	Number			average
	of			exercise
	Options			price
Outstanding, beginning of period		465,294		$	1.67
Granted		4,325,808			0.41
Exercised		-			-
Forfeited/Expired		(6,459	)		-
Outstanding, end of period		4,784,643		$	0.52
Exercisable at the end of period		1,563,696		$	0.57
Weighted average fair value of
options granted during the period				$	0.41

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of  September 30, 2013 was as follows:

						Weighted		Weighted		Weighted
						Average		Average		Average
		Stock		Stock		Remaining		Exercise Price		Exercise Price
Exercisable		Options		Options		Contractual		of Options		of Options
Prices		Outstanding		Exercisable		Life (years)		Outstanding		Exercisable
$	7.20		1,667		1,261		1.98	$	0.46	$	0.46
$	4.50		33,334		15,451		2.15	$	0.53	$	0.53
$	6.00		16,500		10,431		2.23	$	0.36	$	0.36
$	4.20		13,334		6,530		2.79	$	0.36	$	0.36
$	5.15		10,000		4,685		2.88
$	1.70		4,000		1,750		3.01	$	0.36	$	0.36
$	0.89		60,000		18,719		8.76	$	0.36	$	0.36
$	0.89		200,000		58,230		8.84	$	0.36	$	0.36
$	0.89		120,000		32,439		8.93	$	0.36	$	0.36
$	0.43		759,645		759,645		9.54	$	0.36	$	0.36
$	0.43		500,000		500,000		9.76	$	0.36	$	0.36
$	0.41		533,498		4,677		9.96	$	0.36	$	0.36
$	0.44		599,999		35,508		9.96
$	0.38		1,932,666		114,370		9.96
			4,784,643		1,563,696

Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the nine months ended September 30, 2013, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of September 30, 2013 based on the grant date fair value estimated.

Warrants

During the nine months ended September 30, 2013, in conjunction with the Company’s issuance of shares of common stock for cash, the Company granted warrants to purchase a total of 37,427,384 shares of our common stock.  Each warrant is exercisable at a price per share between $0.15 up to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like and will expire in one up to five years from date of grant (see Note 3).

During the nine months ended September 30, 2013, a total of 933,824 purchase warrants were exercised for a total of 811,872 shares of common stock (see Note 3).

During the nine months ended September 30, 2013, the Company amended the exercise price of approximately 4,308,000 warrants issued in 2012, from $0.65 per share to $0.25 per share. The Company calculated the change in fair value of the warrants before and after the modification using the Black Scholes Pricing Option Model and recorded an expense in the statements of operations during the nine months ended September 30, 2013 amounted to $704,575.

A summary of the Company’s warrant activity and related information follows:

	September 30, 2013
				Weighted
				average
				exercise
	Options			price
Outstanding -beginning of period		7,098,104		$	0.79
Granted		37,883,896			0.20
Exercised		(933,824	)		0.30
Forfeited		(857,805	)		1.26
Outstanding - end of period		43,190,371		$	0.31

At September 30, 2013, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	9.30		223,338		223,338		0.75
$	10.20		28,335		28,335		0.88
$	9.00		9,168		9,168		1.06
$	8.70		3,334		3,334		1.12
$	8.40		667		667		1.33
$	8.70		5,000		5,000		1.66
$	5.70		7,334		7,334		1.84
$	4.50		3,334		3,334		1.95
$	4.20		8,334		8,334		1.98
$	4.20		33,334		33,334		1.99
$	3.60		8,334		8,334		2.08
$	4.50		33,334		33,334		2.15
$	4.20		13,335		13,335		2.16
$	6.00		133,334		133,334		2.23
$	6.00		33,334		33,334		2.24
$	6.30		8,334		8,334		2.47
$	5.70		4,001		4,001		2.50
$	6.90		33,334		33,334		2.71
$	6.90		33,334		33,334		2.96
$	1.90		80,000		80,000		3.01
$	6.90		33,334		33,334		3.21
$	1.47		260,000		260,000		3.57
$	0.65		80,000		80,000		3.86
$	0.65		20,000		20,000		4.05
$	0.65		50,000		50,000		4.08
$	0.25		124,000		124,000		4.50
$	0.25		250,000		47,500		4.79
$	0.25		57,692		8,654		4.97
$	0.89		100,000		100,000		9.13
$	0.15 - 0.65		41,512,493		41,512,493		0.01 - 4.70
			43,190,371		42,938,833

XML

Statements Of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,939,237)	$ (6,982,053)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation & amortization	11,263	10,203
Common stock and warrants issued for services	793,751	934,943
Stock compensation expense	223,277	878,604
Loss on change in valuation of derivative liability	3,543,781	14,716
Debt discount and beneficial conversion feature recognized as interest expense	922,152	1,461,223
Gain on settlement of debt	(2,310,953)	838,728
Common stock issued for incentive fees		21,000
Original issue discount amortized as interest		92,662
Non cash interest and commitment fee expense	1,320,810
Fair Value Adjustment of Warrants	704,575
(Increase) Decrease in:
Accounts receivable	5,000	(80,726)
Prepaid expenses	65,811	536,981
Work in progress	(28,934)	219,658
Other receivables	1,200	15,427
Increase (Decrease) in:
Accounts payable	(20,245)	(86,524)
Accrued expenses	7,718	15,289
Deferred income		(278,163)
NET CASH USED IN OPERATING ACTIVITIES	(2,989,484)	(2,378,141)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(45,089)	(12,500)
Patent expenditures	(131,477)	(97,089)
NET CASH USED IN INVESTING ACTIVITIES	(176,566)	(109,589)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from unsecured subordinated debt		1,579,578
Payments for unsecured debt	(10,000)
Proceeds from convertible promissory notes	1,580,000
Proceeds for issuance of common stock	2,387,271	808,896
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,957,271	2,388,474
NET INCREASE/(DECREASE) IN CASH	791,221	(99,256)
CASH BEGINNING OF PERIOD	507,355	197,868
CASH END OF PERIOD	1,298,576	98,612
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid		5,262
Taxes paid

XML

Derivative Liabilities (Details)	9 Months Ended
	Sep. 30, 2013
Significant assumptions used for black scholes valuation of the derivative
Expected dividend yield
Minimum [Member]
Significant assumptions used for black scholes valuation of the derivative
Risk free interest rate	0.05%
Stock volatility factor	29.13%
Weighted average expected option life	6 months
Maximum [Member]
Significant assumptions used for black scholes valuation of the derivative
Risk free interest rate	0.72%
Stock volatility factor	86.88%
Weighted average expected option life	4 years

XML

Derivative Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Derivative Liability [Abstract]

Schedule of Derivative Liabilities at Fair Value

Risk free interest rate		.05% - .72	%
Stock volatility factor		29.13% - 86.88	%
Weighted average expected option life	6 months - 4 years
Expected dividend yield	None

XML

Derivative Liabilities

9 Months Ended

Sep. 30, 2013

Derivative Liability [Abstract]

Derivatives and Fair Value

7.    DERIVATIVE LIABILITIES

In June 2008, the FASB issued authoritative guidance on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. Under the authoritative guidance, effective January 1, 2009, instruments which did not have fixed settlement provisions were deemed to be derivative instruments. As a result, certain convertible notes issued related to the private placement described in Notes 6 do not have fixed settlement provisions because their conversion prices may be lowered if the Company issues securities at lower prices in the future. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.  At December, 31, 2012, the outstanding fair value of the convertible notes accounted as derivative liabilities amounted to $355,526.

During the period ended September 30, 2013, as a result of convertible notes (“Note”) we issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $2,033,406, based upon a Black-Sholes-Merton calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. As the aggregate fair value of these liabilities of $2,033,406 exceeded the aggregate Note value of $1,580,000, the excess of the liability over the Note value of $453,406 was considered as a cost of the private placement and reported in the accompanying Statement of Operation as part of the change in derivative liability.

During the period ended September 30, 2013, approximately $779,208 convertible notes were converted.  As a result of the conversion of these notes, the Company recorded a gain of $2,310,953 due to the extinguishment of the corresponding derivative liability.  Furthermore, during the period ended September 30, 2013, the Company recognized a loss of $3,543,781 to account for the change in fair value of the derivative liabilities.  At September 30, 2013, the fair value of the derivative liability was $2,677,675.

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

Risk free interest rate		.05% - .72	%
Stock volatility factor		29.13% - 86.88	%
Weighted average expected option life	6 months - 4 years
Expected dividend yield	None

XML

Basis of Presentation (Detail Textuals) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net cash used in operating activities			$ 2,989,484
shareholders' deficit	(2,149,051)		(2,149,051)		(540,896)
Working Capital Deficiency	2,709,557		2,709,557
Net loss	$ (1,994,857)	$ (1,922,395)	$ (7,939,237)	$ (6,982,053)

XML

Options and Warrants (Tables)

9 Months Ended

Sep. 30, 2013

Stocks and Warrants [Abstract]

Schedule of company's stock option activity and related information

	September 30, 2013
				Weighted
	Number			average
	of			exercise
	Options			price
Outstanding, beginning of period		465,294		$	1.67
Granted		4,325,808			0.41
Exercised		-			-
Forfeited/Expired		(6,459	)		-
Outstanding, end of period		4,784,643		$	0.52
Exercisable at the end of period		1,563,696		$	0.57
Weighted average fair value of
options granted during the period				$	0.41

Schedule of weighted average remaining contractual life of options outstanding issued under the plan

						Weighted		Weighted		Weighted
						Average		Average		Average
		Stock		Stock		Remaining		Exercise Price		Exercise Price
Exercisable		Options		Options		Contractual		of Options		of Options
Prices		Outstanding		Exercisable		Life (years)		Outstanding		Exercisable
$	7.20		1,667		1,261		1.98	$	0.46	$	0.46
$	4.50		33,334		15,451		2.15	$	0.53	$	0.53
$	6.00		16,500		10,431		2.23	$	0.36	$	0.36
$	4.20		13,334		6,530		2.79	$	0.36	$	0.36
$	5.15		10,000		4,685		2.88
$	1.70		4,000		1,750		3.01	$	0.36	$	0.36
$	0.89		60,000		18,719		8.76	$	0.36	$	0.36
$	0.89		200,000		58,230		8.84	$	0.36	$	0.36
$	0.89		120,000		32,439		8.93	$	0.36	$	0.36
$	0.43		759,645		759,645		9.54	$	0.36	$	0.36
$	0.43		500,000		500,000		9.76	$	0.36	$	0.36
$	0.41		533,498		4,677		9.96	$	0.36	$	0.36
$	0.44		599,999		35,508		9.96
$	0.38		1,932,666		114,370		9.96
			4,784,643		1,563,696

Schedule of company's warrant activity and related information

	September 30, 2013
				Weighted
				average
				exercise
	Options			price
Outstanding -beginning of period		7,098,104		$	0.79
Granted		37,883,896			0.20
Exercised		(933,824	)		0.30
Forfeited		(857,805	)		1.26
Outstanding - end of period		43,190,371		$	0.31

Schedule of weighted average remaining contractual life of warrants outstanding

						Weighted
						Average
						Remaining
Exercisable		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	9.30		223,338		223,338		0.75
$	10.20		28,335		28,335		0.88
$	9.00		9,168		9,168		1.06
$	8.70		3,334		3,334		1.12
$	8.40		667		667		1.33
$	8.70		5,000		5,000		1.66
$	5.70		7,334		7,334		1.84
$	4.50		3,334		3,334		1.95
$	4.20		8,334		8,334		1.98
$	4.20		33,334		33,334		1.99
$	3.60		8,334		8,334		2.08
$	4.50		33,334		33,334		2.15
$	4.20		13,335		13,335		2.16
$	6.00		133,334		133,334		2.23
$	6.00		33,334		33,334		2.24
$	6.30		8,334		8,334		2.47
$	5.70		4,001		4,001		2.50
$	6.90		33,334		33,334		2.71
$	6.90		33,334		33,334		2.96
$	1.90		80,000		80,000		3.01
$	6.90		33,334		33,334		3.21
$	1.47		260,000		260,000		3.57
$	0.65		80,000		80,000		3.86
$	0.65		20,000		20,000		4.05
$	0.65		50,000		50,000		4.08
$	0.25		124,000		124,000		4.50
$	0.25		250,000		47,500		4.79
$	0.25		57,692		8,654		4.97
$	0.89		100,000		100,000		9.13
$	0.15 - 0.65		41,512,493		41,512,493		0.01 - 4.70
			43,190,371		42,938,833

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 18, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINOIL INC
Entity Central Index Key	0001419793
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2013
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		48,653,092

XML

Convertable Promissory Notes (Tables)

9 Months Ended

Sep. 30, 2013

Convertible Promissory Notes [Abstract]

Schedule of convertible derivative valuation assumptions

Risk free interest rate		.06% - .15	%
Stock volatility factor		37.24% - 66.35	%
Weighted average expected option life	6 months - 13 months
Expected dividend yield	None